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Regeneration in the aging peripheral nervous system 
 
Abstract 
 
In the peripheral nervous system (PNS), aging is associated with a number of 
disorders, including a decline in regenerative capacity after injury. Although this 
decline has been observed in both rodents and humans for decades, the cellular 
and molecular underpinnings of this defect have remained elusive. As such, the 
goal of this thesis was to elucidate, at least in part, how aging impinges on 
axonal regeneration.  
  
In this work, we demonstrate a progressive, age-dependent slowing in the 
recovery of sensory and motor function following peripheral nerve injury. A 
systematic investigation of the possible causes follows, focusing on the potential 
roles of neuronal intrinsic growth, immune cell function, and Schwann cell 
responses. Unexpectedly, an array of in vitro, in vivo and in silico experiments 
provide no evidence that neuronal intrinsic growth is altered with aging. In 
addition, exposure of youthful circulating factors to aged mice fails to rescue the 
age-associated phenotype, implying that macrophage-intrinsic defects are 
unlikely to be involved. In contrast to these results, functional recovery in aged 
animals can be fully rejuvenated by transplantation of young nerve grafts. 
 iv 
Likewise, aged nerve grafts transplanted into young hosts results in diminished 
axonal regeneration. Microarray profiling of young and aged sciatic nerves 
reveals a highly perturbed transcriptional landscape, with the regulation of genes 
associated with the function of Schwann cells being particularly aberrant. These 
alterations are mirrored functionally, as aged Schwann cells fail to efficiently de-
differentiate and engulf myelin. Finally, it is also noted that the protein expression 
of a key regulator of Schwann cell injury responses, c-Jun, is altered in aging 
nerves. Taken together, this thesis work shows that extrinsic factors are sufficient 
to rejuvenate age-associated decline in nerve regeneration, and suggest 
Schwann cells as key effectors of the aging PNS.  
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PART I: SEARCHING FOR THE SCIENTIFIC FOUNTAIN OF YOUTH: WHY 
AND HOW WE AGE 
 
"All children, except one, grow up." 
- J.M. Barrie, Peter Pan 
 
Introduction 
  
As a literature and philosophy student in college, it is probably not a coincidence 
that I picked aging as a topic of study upon entering the field of biology. Is there 
any other subject, save for death and love, that has been so deeply and 
continually probed by artists and philosophers? From Buddha's recognition of 
aging as an inevitable part of human suffering, to Shakespeare’s meditative 
sonnets on growing older, to Mark Twain's glib remark that, "Life would be 
infinitely happier if only we could be born at the age of eighty and gradually 
approach eighteen," the sense of loss that accompanies aging is a powerfully 
existential emotion, and one that has ignited countless efforts, from the spiritual 
to the scientific, to understand why we age and what we can do to thwart its ill 
effects.  
 
Perhaps the most enduring anti-aging panacea was first described by the fifth 
century Greek historian Herodotus. Recounting a legendary race of people who 
lived on average to the age of 120, he described the secret to their longevity as, 
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"...a certain spring, in the water of which they washed became more sleek of 
skin..." (Herodotus, 1890). The myth of the Fountain of Youth, as it was later 
called, was so compelling that it was perpetuated for centuries, disseminating 
through the stories of Alexander the Great and Prester John before being carried 
whole heartedly into the middle ages by Ponce de Leon, a Spanish explorer who 
searched for the Fountain in what is now Florida (somewhat ironically the state 
with the highest percentage of senior citizens). Alas, while he was unsuccessful 
in his pursuit, there is perhaps some solace for the ghost of Ponce de Leon: the 
quest for the Fountain of Youth continues today, not as an archaeological 
treasure hunt, but as a scientific endeavor to understand the basic biological 
mechanisms of aging and develop therapeutics that extend health and lifespans.  
 
From a healthcare standpoint, this endeavor has arguably never been more 
important than now. Diseases and disorders of aging represent a rapidly 
escalating worldwide problem. Currently, the worldwide average age is the 
highest in history, and the number of persons over the age of 65 is predicted to 
double over the next several decades (Caspari and Lee, 2004). This means large 
increases in age-associated diseases, including cancer, arthritis, osteoporosis, 
cardiovascular disease, and type-2 diabetes. Financially, this places a 
tremendous burden on the economy, where typical government systems of 
paying for the healthcare costs of the elderly, such as Medicare, become 
increasingly difficult as a greater percentage of the population is of advanced 
age. Indeed, neurodegenerative disorders represent major healthcare burdens, 
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where, for example, it is estimated that nearly 15% of persons over the age of 70 
have dementia at a cost comparable to that of heart disease and cancer (Hurd et 
al., 2013). These statistics underscore the importance of both basic and 
translational age-related research. 
 
Why do we age?  
 
Despite tremendous advances in molecular biology over the last fifty years, aging 
remains in many ways a mysterious biological process. Although aging is a 
fundamental feature of most organisms, we still do not truly understand "why" we 
age in evolutionary terms. Part of this conundrum is the counterintuitive 
knowledge that aging is an evolutionarily conserved process, and yet, is thought 
to result from the absence of selective pressure. As such, there has been (and is 
still) considerable debate over a "theory" of aging that might explain all of its 
aspects while keeping in mind the guiding principles of Darwinian evolution. So 
far, many philosophical theories have been proposed, but none crowned the 
winner in the consensus of science.  
 
Among the first theories of aging came from the German evolutionary biologist 
August Weisman, who proposed the "programmed death theory" in the late 19th 
century. According to Weisman, aging is essentially the process of eliminating 
inferior genetic material out of the population. In his view, each successive 
generation of a particular organism is a little "better" in an evolutionary sense, 
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being ever so slightly more adapted to its environment. Aging (and consequently 
death) thus serves to weed out the poorer genes of the population and clear the 
way for competitive resources such as food (Weisman, 1889). Though sensible 
on the whole, Weisman's argument fails to explain why aging happens gradually 
with time, as opposed to an immediate death. In addition, his theory does not 
account for the fact that, in the wild, most animals will never have the opportunity 
to die of old age; they will be killed by predators. Nevertheless, Weisman's 
attempt paved the way for others.   
 
Over time, Weisman's programmed death theory expanded into the more modern 
"disposable soma theory," first articulated by Thomas Kirkwood in the 1970s 
(Kirkwood, 1977). Still frequently cited in literature today, Kirkwood argues that 
aging is the by-product of finite energy resources. With limited food, an organism 
cannot adequately allocate resources to both reproduction and the metabolically 
costly chore of maintaining and repairing somatic tissues. As a result, just 
enough energy is given to somatic maintenance for an organism to stay healthy 
through reproduction (and perhaps a bit longer in some cases to care for the 
young). Aging thus represents the accumulation of unrepaired somatic damage.  
 
This is an intuitively attractive theory that fills in a major gap of Weisman's, 
namely in taking into account extrinsic mortality. Still, there are some notable 
flaws with the theory, such as the fact that reproduction is significantly more 
metabolically demanding for women than for men, and yet women have a 
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longevity advantage at all ages after birth (though this is not necessarily true for 
all species). In addition, one of the truly robust findings in the field of aging has 
been that restricting caloric intake extends lifespan. Clearly, this is the opposite 
of what disposable soma theory would predict when reducing the overall energy 
intake of an organism.  
 
Contemporary theories 
 
Today, understanding "why we age" is most often seen through the lens of two 
interrelated theories: mutation accumulation theory and antagonistic pleiotropy. 
Articulated by Medawar in 1952, mutation accumulation theory proposes that 
aging results from a decline in selection power against deleterious mutations that 
only manifest later in life (Medawar, 1952). Because animals are often killed in 
the wild, there is tremendous selection against traits that are deleterious at a 
young age due to loss of fitness. On the other hand, mutations expressed later in 
life are not selected against because they will often be passed down to the next 
generation before the effects of these mutations are observed. Thus, mutations 
will accumulate with aging that will not be selected against, leading to negative 
effects with advancing age. This conveniently explains why diseases such as 
Huntington's, which is the result of a mutation that manifests later in life, remain 
in the population. Experimentally consistent with these observations, flies that 
have been heavily inbred show dramatic increases in deleterious effects with 
age, largely as mutation accumulation theory might predict (Hughes et al., 2002). 
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Similarly, spontaneous mutations in flies tend to exert their negative effects within 
defined age-ranges (Pletcher et al., 1998).  
 
The differences between mutation accumulation theory and antagonistic 
pleiotropy theory are slight but important. Whereas in mutation accumulation 
theory, deleterious traits develop because evolution essentially does not care 
about them, in antagonistic pleiotropy, these traits are actually directly selected 
for. This theory relies on the fact that many, if not all, genes are pleiotropic, likely 
exerting some beneficial effects and some negative ones. From an evolutionary 
point of view, a small beneficial effect early in life will thus greatly outweigh a 
large negative effect later in life. Again, this is because in the wild animals are 
likely to be killed, and thus there is significant selective pressure for genes that 
confer a benefit early in life. Perhaps one of the most illustrative examples of 
antagonistic pleiotropy is the tumor suppressor gene, p53. Mice with increased 
expression of p53 show better resistance to tumors, but their longevity is reduced 
(Jenkins et al., 2004; Tyner et al., 2002). Generally speaking, there is also a well-
demonstrated inverse correlation between longevity and fitness. For example, 
although a mutation in DAF-2 doubles the lifespan of C. elegans, amazingly this 
allele is nearly eliminated from a population of worms in approximately four 
generations (Jenkins et al., 2004).  
 
Overall, although it is interesting to philosophize about an evolutionary theory 
that will explain aging in grand unified terms, it is perhaps more plausible to 
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believe that no single idea will prove sufficient to explain all aspects of such a 
complex process. In this regard, it seems reasonable to think that mutation 
accumulation theory and antagonistic pleiotropy are not mutually exclusive, with 
both explaining slightly different potential mechanisms for why aging occurs.  
 
How we age: fundamental pathways that regulate aging  
 
For a long time, aging was considered to be a stochastic process, a kind of 
haphazard series of events that eventually leads to an equally random death. 
But, as is so often the case, "stochastic" tends to be a catch-all phrase in biology 
for processes we don't fully understand, and as we have elucidated pathways 
that regulate it, our view of aging as stochastic has faded.  
 
Ironically, though this view is long passé, there is indeed some evidence to 
suggest that at least part of aging is indeed haphazard. In an intriguing study, 
Rea et al. demonstrated that individual C. elegans respond with different degrees 
of stress when exposed to an unwanted stimulus (Rea et al., 2005). Amazingly, 
the amount of stress induced in each worm, as indicated by a heat-shock protein 
reporter, predicted the longevity of these animals, with greater stress-responders 
living longer lives. Interestingly, the amount of stress-response in each animal 
was not heritable, demonstrating it was not the result of some genetic or 
epigenetic alteration, but rather a seemingly random response to an outside 
stimulus.    
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These data aside, it is somewhat surprising that there was such resistance to the 
idea that aging might be under genetic control given the extreme variability in the 
lifespans of different animals. For example, the mayfly lives 24 hours or less, 
while some species of tortoises can live for hundreds of years. Still, it took many 
years before conclusive evidence was provided that aging was subject to genetic 
regulation: in 1993, Cynthia Kenyon and colleagues published a paper 
demonstrating that a mutation in a single gene, DAF-2, which encodes for the 
insulin like growth factor (IGF-1) in worms, could double the lifespan of C. 
elegans (Kenyon et al., 1993). This was a landmark discovery that has since 
served as a cornerstone for all future age-related research.  
 
Since demonstrating that a partial loss of function mutation in the insulin/IGF 
receptor increases the lifespan in worms, it has also been demonstrated in yeast, 
flies and mice (interestingly, complete absence of insulin signaling often results in 
reduced lifespan) (Kenyon, 2005). Furthering the significance of the insulin 
pathway in aging, other components of the insulin signaling pathway have been 
perturbed across a variety of species, all with the result that "turning down" 
insulin signaling has a beneficial effect on longevity (Figure 1.1). For example, 
mutations that reduce AGE-1 (PI3K) also increase lifespan in worms (Morris et 
al., 1996) while over-expression of DAF-16/FOXO in drosophila extends lifespan 
(Giannakou et al., 2004). These findings extend, at least correlatively, to humans, 
where an over-representation of IGF1R mutations was found among a group of 
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female centenarians (Suh et al., 2008). Similarly, a deficiency in growth hormone 
receptor has been shown to correlate with reduced incidence of cancer and 
diabetes, but not necessarily lifespan (Guevara-Aguirre et al., 2011). Overall, it 
remains to be understood how exactly insulin signaling influences organismal 
aging, and whether it exerts its influence uniformly, through all tissues, or via 
certain master tissues or even cell types.  
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FIGURE 1.1: Main insulin signaling axis in aging. Insulin or growth hormone bind 
to the insulin receptor (DAF-2/IGF1R) leading to the inactivation of FOXO via 
AKT driven phosphorylation of DAF-2/FOXO. FOXO promotes a number of 
functions, including enhanced autophagy and increased stress response.   
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Other factors 
 
One of the earliest discovered interventions that can modify longevity was caloric 
intake. In the 1930s, a seminal study demonstrated that reducing the amount of 
food rats consumed extended their lifespans (C.M. McCay, 1935). Since then, 
caloric restriction as a way of extending longevity has become one of the most 
reliable findings in the literature of aging, being reproduced in yeast, flies, worms, 
rodents and to some degree monkeys (still ongoing and still controversial) 
(Guarente, 2013). Interestingly, the mechanisms underpinning increased 
longevity from caloric restriction are not understood, but are variously thought to 
involve stress responses, insulin signaling or perhaps mediated via sirtuin activity 
(Guarente, 2013).  
 
Cellular senescence is considered to be the state in which a cell has lost its 
proliferative potential while still remaining metabolically active. This can occur for 
a variety of reasons, including the well-described shortening of telomeres, but 
also because of DNA damage or the activation of oncogenes. Senescence is 
often posited to be a major driver of aging and diseases of aging, however, 
evidence in support of this view is scant. This is especially true in addressing the 
role of senescent cells in normal aging, which is perhaps experimentally 
intractable. Still, in the context of progeroid syndromes ("accelerated aging"), 
clearance of senescent cells in a mouse model does delay certain age-related 
tissue pathologies (Baker et al., 2011). Therapeutically speaking, however, it is 
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unclear whether deletion of senescent cells would have an overall beneficial 
effect on health, as it has been suggested (in keeping with the antagonistic 
pleiotropy theory of aging) that senescent cells have an anti-oncogenic effect 
early in life. In some sense, it is still mysterious why the activation of oncogenes 
would result in non-dividing but metabolically active cellular phenotype instead of 
simply death through apoptosis (Braig et al., 2005).  
 
Mitochondria are also thought to play a central role in aging, especially in the 
context of oxidative stress. ATP production by mitochondria requires electrons to 
go through the mitochondrial electron transport chain (ETC), eventually 
producing H20 and C02 through reduction of oxygen. Although this process is 
efficient, some of the 02 is not used up and thus becomes a free-radical capable 
of damaging DNA. Moreover, because mitochondria lack histones to protect its 
DNA, the mitochondrial DNA itself is highly susceptible to oxidative stress, 
creating a locally vicious cycle of damage and free-radical production. Evidence 
in support of this hypothesis includes the finding that knockdown of certain parts 
of the ETC results in greater longevity in fruit flies (Copeland et al., 2009) and 
that mutations in particular genes that confer longevity in worms results in 
decreased ETC function (Hekimi and Guarente, 2003). Again, however, whether 
free-radicals are a major mechanism of normal aging is not clear.  
 
 
 
 14 
 
Towards a therapeutic? 
 
Aging results in many cellular and tissue changes, and there are a host of 
potential mechanisms I have not touched on, such as the role of protein 
aggregation and homeostasis, autophagy, DNA repair pathways and sirtuins. But 
given all that we have learned over the last twenty years about the pathways 
implicated in aging, are we any closer to finding a Fountain of Youth in the form 
of a drug? Although Google recently founded Calico, a company dedicated to 
anti-aging research, the answer, unfortunately, appears to be not really.  
 
Why have therapeutics against aging been so elusive? There are many potential 
reasons. As discussed earlier, and in line with antagonistic pleiotropy, many 
pathways that regulate longevity also have important roles in other vital functions. 
For example, though hydrogen peroxide is implicated as a free-radical in 
oxidative stress, it is also used in the cell as a signaling molecule. Thus, drugs 
modifying many of these pathways or molecules will have to achieve a kind of 
delicate balance that may pose a substantial challenge in terms of creating a 
beneficial therapeutic window. For example, the insulin signaling pathway 
discussed earlier may seem like an easy drug target, but dampening the pathway 
too much often results in a shortening of lifespan. In addition, not all tissues are 
created equal in their control over the aging process. Brain, muscle and fat, for 
instance, have all been shown to regulate certain aging processes at the 
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organismal level (how this is achieved remains a mystery). Thus, achieving 
tissue specificity will most likely be a desired, if not required, component of any 
drug against normal aging.  
 
Perhaps, in the end, it will come down to what most of our doctors have been 
telling us all along: eat a little less, exercise a little more. For now, this is the 
unfortunate-for-the-lazy consensus derived from several decades of age-related 
research.   
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PART II: GOOD AXON, BAD AXON: REGENERATION IN THE NERVOUS  
SYSTEM 
 
"The incapacity of the central nervous pathways to regenerate is a dogma 
accepted by science..." 
- Ramon y Cajal 
 
Introduction 
 
The fact that axons of the peripheral nervous system (PNS) are capable of 
regenerating and reinnervating their downstream targets, whereas those of the 
central nervous system (CNS) generally are not, has remained both a formidable 
biological puzzle as well as the source of massive defects for patients suffering 
from brain or spinal cord injuries. Indeed, according to the National Institute of 
Neurological Disorders and Strokes, there are an estimated quarter of a million 
people living with spinal cord injury in the U.S. alone, along with nearly 800,000 
strokes each year. Given this, advancing our understanding of what promotes 
neuronal regeneration is a critical scientific endeavor. Because the PNS is, in a 
sense, a mammalian model in which neuronal regeneration can be achieved, it 
represents a unique opportunity to understand mechanisms of regeneration in a 
mammalian system.  
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Historical work 
 
Why do neurons of the CNS fail to regenerate axons? Broadly speaking, this 
could be due to either properties of the neurons themselves or the environment 
in which they reside, or both. Although distinguishing between these possibilities 
has been a fundamental goal of regeneration research, it is still a question that 
remains elusive today.  
 
Early on it became apparent that the intrinsic growth of CNS neurons could be 
reactivated. In the beginning of the 20th century, Cajal described the work of his 
student Tello, in which he demonstrated that transplantation of sciatic nerve 
grafts into the cerebral cortex promoted regeneration in "white matter" (Cajal, 
1991). This led Cajal to conclude that CNS neurons can regenerate if provided 
with a suitable environment. Many decades later, in the 1980s, these 
experiments were reproduced in a modern context by Agauyo and colleagues, 
who showed that regeneration could be obtained in the spinal cord if axons were 
permitted to regrow through a segment of sciatic nerve (Richardson et al., 1980). 
This work strengthened the idea that regeneration in the CNS was primarily an 
issue of location.  
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An inhibitory CNS 
 
Subsequent work in the field focused on elucidating the inhibitory nature of the 
CNS environment. To this end, several inhibitory elements were identified in 
myelin, which is not adequately sequestered in the CNS, such as myelin-
associated glycoprotein (MAG) (McKerracher et al., 1994), Nogo (Chen et al., 
2000) and oligodendrocyte-myelin glycoprotein (OMgp) (Kottis et al., 2002). On 
the neuronal side, receptors that bind to these inhibitory ligands were also 
discovered, notably Nogo-Receptor (NgR) (Fournier et al., 2001) and Paired-
immunoglobulin-like receptor B (PirB) (Atwal et al., 2008).   
 
Another feature of CNS injury that does not occur within the PNS is the formation 
of a glial scar. This scar, which is thought to be composed largely of astrocytes 
as well as invading microglia and/or macrophages, creates a physical barrier that 
impedes axonal regeneration past the site of injury. Moreover, specific inhibitors 
of regeneration within the glial scar have also been identified, namely chondroitin 
sulfate proteoglycans (CSPGs) and keratan sulfate proteoglycans (KSPGs), 
(Silver and Miller, 2004). Likewise, the absence of receptors for these ligands on 
neurons, such as PTPsigma, promotes regeneration on inhibitory substrates 
(Shen et al., 2009).  
 
Despite this knowledge, achieving substantial neurite outgrowth in the CNS, or 
functional recovery, has been limited when solely trying to overcome inhibitory 
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effects. For example, genetic deletion of the Nogo-receptor does not lead to 
increased neurite outgrowth (Zheng et al., 2005).  
 
Neuronal intrinsic growth 
 
The relative lack of success in promoting regeneration in the CNS through the 
disruption of inhibitory signals alone has spurred substantial investigation into the 
intrinsic growth potential of the neurons themselves. During development 
mammalian neurons grow, the local environment is permissive for such growth, 
and guidance cues are present that match the neurons with their specific targets, 
collectively leading to formation of functional neural circuits. In mature 
differentiated neurons the molecular machinery necessary for intrinsic growth is 
absent. However, injury to axons in the peripheral nervous system (PNS) 
increases intrinsic growth in sensory and motor neurons, and in optimal 
conditions, regeneration occurs, with restoration of function.  
 
Improvement of intrinsic growth capacity has perhaps been most convincingly 
shown by “pre-conditioning” experiments in which a crush injury is performed on 
the nerve followed by a more proximal second crush. This pre-conditioning 
greatly boosts the rate of axonal regeneration (Forman et al., 1980). Pre-
conditioning can also be demonstrated in vitro, where previously injured dorsal 
root ganglia (DRG) neurons have more robust neurite outgrowth than naïve 
neurons under permissive conditions (see Chapter 2). Importantly from a 
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potential clinical standpoint, a pre-conditioning injury can also permit axons to 
overcome a normally inhibitory environment. For example, if the central branch 
(the axon within the dorsal column in the spinal cord that does not normally 
regenerate) of a DRG neuron is injured, along with an injury to the peripheral 
branch, the central branch can now regenerate into the spinal cord (Neumann 
and Woolf, 1999). Similarly, pre-conditioning is robustly recapitulated in vitro, 
where a nerve injury prior to culture of DRG sensory neurons results in massively 
increased axonal growth both under permissive and non-permissive conditions. 
How exactly pre-conditioning overcomes inhibitory environments is not well 
understood: does injury lead to the down-regulation of inhibitory receptors, or 
does it simply cause so much growth that it ignores any blocking signals?  
 
In any case, the intrinsic growth capacity and pre-conditioning effect of PNS 
neurons is thought to be largely driven by the activation of transcriptional 
regulatory programs. Collectively, these programs are composed of  
"regeneration-associated genes (RAGs)" and several hundred of them are up or 
down-regulated after injury (see Appendix).  
 
Among these genes, many of them reproduce transcriptional programs utilized 
during development, suggesting common growth promoting mechanisms (e.g. 
GAP-43) (Benowitz and Routtenberg, 1997) while others (e.g. Sprr1a) are unique 
in their induction after peripheral nerve injury (Starkey et al., 2009). Importantly, it 
has been shown that cAMP levels increase in DRG neurons after a nerve injury 
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and this mechanism can allow central branches of DRG neurons to regenerate 
after dorsal column lesions (Qiu et al., 2002). In this sense, cAMP mimics pre-
conditioning. In the search for transcription factors, several have been found. 
Notably, Activating Transcription Factor 3 (ATF3) enhances regeneration as 
ATF3-over-expressing mice regenerate their sensory axons more readily than 
wild-type mice after sciatic nerve injury (Seijffers et al., 2007). Likewise, c-Jun, 
which forms part of the AP-1 complex along with ATF-3, has also been 
demonstrated to be necessary for axonal regeneration (Raivich et al., 2004). In 
addition to these transcription factors, a number of other molecules have also 
been implicated in axonal regeneration in the PNS such as  sterile 20-like 
kinases (Lorber et al., 2009) and heat-shock proteins (Benn et al., 2002; Ma et 
al., 2011). The precise mechanisms of how these molecules act, however, has 
not been elucidated.  
 
Despite this progress, it is safe to say that the promise of recapitulating intrinsic 
growth potential of the PNS into the CNS has not yet been realized. No truly 
robust "master-regulator" of intrinsic growth has been identified, and future work 
should address the role of the entire network of RAGs rather than individual 
genes.  
 
In the CNS, intrinsic growth programs are not induced by normal injury. For 
example, optic nerve crush in mice often leads to death rather than regrowth of 
retinal ganglion cells (RGCs) (Watkins et al., 2013). Still, recent work has 
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demonstrated the power of enhancing neuronal-intrinsic mechanisms in the CNS. 
Importantly, deletion of either PTEN or SOCS3 results in significant axonal 
regeneration in the optic nerve (Park et al., 2008; Smith et al., 2009). Moreover, 
double deletion of both PTEN and SOCS3 permits extraordinarily robust optic 
nerve regeneration (Sun et al., 2011). Interestingly, though the absence of these 
factors in RGCs clearly enhances intrinsic growth, it does not mimic the injured 
state of DRG neurons in the PNS, where both PTEN and SOC3 are expressed 
during regeneration (Sun et al., 2011). This highlights the potential differences in 
the transcriptional programs utilized to stimulate growth in these two different 
systems. Furthermore, it is interesting to speculate as to why there is an active 
regulatory presence of two genes that serve to seemingly constrain growth in 
these neurons. Would uninhibited growth of neurons in the CNS actually lead to 
damaging consequences? One could imagine, for instance, that evolution has 
favored the absence of regeneration in the CNS in order to prevent mis-wiring, 
leading to even more destructive consequences, or that adequately clearing the 
CNS environment through a Wallerian-like degeneration process might 
unnecessarily expose the CNS to the potential for autoimmunity.  
 
Non-neuronal responses 
 
Non-neuronal cells also play a critical role in axonal regeneration, one that is well 
described in the PNS and increasingly recognized in the CNS. Among non-
neuronal cells, the best characterized in the context of regeneration are Schwann 
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cells and macrophages. One important role of these cells during regeneration is 
to clear debris from the distal stump of the nerve and make the site permissible 
for axonal regeneration. This process is referred to as Wallerian degeneration, 
and it is substantially slower in the CNS. During Wallerian degeneration, 
macrophages are recruited into the degenerating nerve and serve as a major 
pathway of phagocytosis of myelin and axonal-derived debris. Schwann cells 
also sequester and phagocytose myelin, a function that is particularly important 
at early time points after nerve injury (see Chapter 2).  
 
The role of macrophages has recently been underscored by studies showing that 
macrophages are necessary for axonal regeneration in the PNS. Impressively, 
Barrett et al. demonstrated that deletion of CD11b+ cells (macrophages, 
monocytes and granulocytes) completely abolishes neuronal regeneration 
(Barrette et al., 2008). Whether this result is simply due to efficient debris 
clearance or if macrophages directly promote regeneration via secretory factors 
or cell-cell/cell-axon interactions remains to be elucidated. Equally interesting has 
been work in the CNS showing that recruitment of innate immune cells can 
enable optical nerve regeneration (Yin et al., 2003; Yin et al., 2006). This is 
driven, at least in part, by oncomodulin, a neutrophil and/or macrophage derived 
factor capable of directly stimulating the growth of retinal ganglion cells (Kurimoto 
et al., 2013; Yin et al., 2006). Taken together, these studies suggest an important 
and broadening role for cells of the innate immune system in regeneration. In the 
future, it will be interesting to investigate other inflammatory cells, such as those 
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of the adaptive immune system, which are present for long periods after nerve 
injury and whose functions are completely unknown with regard to axonal 
regeneration.  
 
Aside from sequestering and clearing myelin, Schwann cells in the distal stump 
that have lost contact with degenerated axons undergo de-differentiation and 
begin to proliferate rapidly (Mirsky and Jessen, 1996). This de-differentiation 
process, in which Schwann cells essentially trans-differentiate into non-
myelinating "repair cells" is a key event in Wallerian degeneration. Recently, the 
transcription factor c-Jun was identified as a kind of "master-regulator" of 
Schwann cell de-differentiation. When c-Jun is conditionally ablated in the 
Schwann cell compartment, axonal regeneration in the PNS is severely limited 
(Arthur-Farraj et al., 2012). These results also serve to underscore the 
importance of Schwann cell activities in permitting optimal regeneration, a 
function often overlooked in the context of neuronal intrinsic growth.  
 
Although c-Jun is clearly a major player in Schwann cell function, the molecular 
mechanisms that trigger, govern and maintain the de-differentiated Schwann cell 
state remain largely unexplored. Recent work has shown that specific activation 
of the ERK pathway in Schwann cells is sufficient to drive de-differentiation 
(Napoli et al., 2012). Interestingly, this work also demonstrated that c-Jun 
activation appeared to be downstream of ERK signaling. Other kinase pathways, 
however, are also capable of inducing de-differentiation, including both JNK 
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(Monje et al., 2010) and the p38 MAPK (Yang et al., 2012). Importantly, though, 
how Schwann cells sense injury and activate these kinase pathways is unknown, 
as is the question of how these kinase pathways interact or overlap to 
simultaneously enforce the repair cell phenotype while blocking the myelinating 
Schwann cell phenotype.  
 
In their de-differentiated state, these repair cells form so-called “bands of 
Bungner” in the distal stump, creating a tunnel-like structure that is essentially a 
physically permissive environment for the regenerating axon. These bands also 
serve to permit subsequent re-myelination of new axons (Chen et al., 2000). 
Aside from these structural functions, Schwann cells also play a more direct role 
in promoting axonal regeneration by secreting neurotrophic factors that help to 
promote neuronal survival after injury (Koliatsos et al., 1993) and induce axon 
growth by initiating a signaling cascade that leads to the regulation of 
cytoskeleton binding proteins (Zhou et al., 2004). In addition, Schwann cells 
produce factors that form key components of the extra-cellular matrix (ECM), 
another part of the overall permissive PNS environment. One component of the 
ECM, laminin, is a permissive substrate in vitro, and likely a critical portion of the 
regeneration enabling environment in vivo (Luckenbill-Edds, 1997).   
 
 
Future directions 
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Despite the somewhat prevailing belief that we have learned most of what there 
is to learn about regeneration in the PNS, there is still a substantial amount we 
do not yet understand, and by extension, much that we might learn about why 
regeneration does not proceed in the CNS.  
 
As an example, we have only scratched the surface in terms of understanding 
how immune cells interact with neurons during regeneration. This is true for both 
the PNS, in which there is a well defined immune invasion of the sciatic nerve, 
but also the CNS, in which inducing inflammation with zymosan can promote 
significant axonal regeneration (Yin et al., 2003). At the level of the distal stump, 
we have thus far relegated immune cells to glorified vacuum cleaners, but given 
the depth and breadth of the inflammatory response (involving at a minimum 
monocytes, macrophages, neutrophils, NK, B- and T-cells) it seems highly likely 
they play unknown roles in axonal regeneration. Furthermore, the "non-
immunological" role of immune cells is being increasing appreciated, where it 
was recently discovered that regulatory T cells actually help orchestrate 
regeneration in the muscle by directly secreting a factor capable of stimulating 
muscle stem cell differentiation (Burzyn et al., 2013). Given that regulatory T cells 
enter the distal stump shortly after nerve injury and persist there for at least thirty 
days (unpublished data not shown), it seems likely they may play a similar role in 
promoting regeneration in the PNS.  
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Given the breadth of tools available in immunology for enhancing and ablating 
various immune cells subsets (knockouts, depleting antibodies) the time is ripe 
for elucidating the roles of these cell-types. Using an anti-ly6G depleting 
antibody, we directly tested the contribution of neutrophils in promoting 
regeneration in vivo, and found no difference in functional recovery after injury in 
mice lacking these cells (see Appendix). Interestingly, these results are in stark 
contrast with work done in the CNS demonstrating an important role for 
neutrophils in permitting axonal regeneration of the optic nerve (via secretion of 
the growth-promoting factor oncomodulin) (Kurimoto et al., 2013). Again, this 
suggests large differences in the mechanisms of CNS vs. PNS regeneration. If 
neutrophils are not necessary for axonal regeneration in the PNS, what role do 
they play considering their large numbers in the distal stump after nerve injury? 
Do neutrophils in the PNS secrete oncomodulin, and if so, are DRG neurons 
receptive to it  in the same way that RGCs are?  
 
Another major challenge in the field of peripheral regeneration has been to 
adequately distinguish the contributions of individual cell types. For example, 
much of what we have learned about neuronal intrinsic growth has come from 
transcriptomic studies of the whole DRG tissue. Although the DRG is certainly a 
decent surrogate for sensory neurons, it also contains glia, immune cells and 
fibroblasts. While the expression of individual genes within sensory neurons can 
be readily confirmed via in situ hybridization, in attempting to reconstruct entire 
genetic regulatory networks that may underlie regeneration-promoting programs, 
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this task becomes much more difficult, and by extension it is impossible to say 
whether certain transcriptional modules are a feature of neurons or non-neuronal 
cells. Thus, in the future, it will be worthwhile to elucidate the roles of non-
neuronal cells within the DRG.  
 
In a similar context, the field has tended to think of neuronal intrinsic growth as a 
predominately neuronal-driven event, for example, as a result of retrograde 
signals after injury (Rishal and Fainzilber, 2010). However, it seems plausible 
that signals derived during Wallerian degeneration, produced by either Schwann 
cells or immune cells, might also contribute to the activation of regeneration-
associated gene-expression programs in neurons. To this end, Takao Omura 
and I observed a striking effect on in vitro pre-conditioning of DRG sensory 
neurons in the presence or absence of non-neuronal cells (see Appendix). 
Although this does not necessarily reflect the more complex in vivo environment, 
it does suggest that non-neuronal cells, especially those contained with the DRG 
itself, have the capacity to modulate the intrinsic growth capacity of sensory 
neurons. This model intuitively make sense; perhaps non-neuronal cells in either 
the proximal stump or DRG react to injury by secreting factors that in turn 
promote the transcriptional activation of RAGs in sensory neurons. To put it 
succinctly, perhaps intrinsic growth is partially activated by extrinsic factors.  
 
Finally, along these lines, I have noted, as have others, the strange correlation 
between the transcriptional programs activated after injury in the DRG and in the 
distal stump (see Appendix). Among the transcripts up-regulated in Schwann 
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cells after nerve injury are c-Jun, ATF-3 and GAP-43, all important genes in the 
context of neuronal intrinsic growth. These data not only suggest caution in 
interpreting studies that assess the role of purported intrinsic growth genes 
through global knockout studies, but beg the question of why such a large degree 
of transcripts would be shared between these cells types. Though perhaps a bit 
farfetched for lack of evidence, it is interesting speculate as to whether this 
phenomenon may serve a functional purpose, such as controlling local protein 
synthesis in axons themselves (Court et al., 2008).  
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PART III: GREYING NEURONS: AGING IN THE PERIPHERAL NERVOUS 
SYSTEM 
 
Aging and the PNS 
 
While aging exerts its effects across all tissues, the nervous system is perhaps 
particularly vulnerable to age-related diseases and disorders. Although disorders 
involving the CNS, such as Alzheimer's, Dementia and Parkinson's are well 
appreciated from both a clinical and biological standpoint, age-associated 
changes in the PNS also strike the elderly frequently, and meaningfully contribute 
to a decreased quality of life.  
 
One clear age-related change in the PNS is the gradual decline in nerve 
conduction velocity with increasing age. This decline has been demonstrated in a 
variety of species, including humans, and is associated with a host of 
physiological and structural changes within the nerves themselves (Adinolfi et al., 
1991; Chase et al., 1992; Dorfman and Bosley, 1979; Verdu et al., 2000). 
Importantly, the amount of fiber in the nerve decreases with age. One study, for 
example, demonstrated in mice that nerves begin to show a rapid decrease in 
fiber after 20 months of age, with unmyelinated fibers being more vulnerable than 
myelinated ones (Verdu et al., 2000). Overall, reduced nerve conduction velocity 
in the elderly is likely the result of both shrinking axon diameter and reduction in 
myelination (Adinolfi et al., 1991; Chase et al., 1992). The reduction in 
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myelination is at least in part due do decreased expression of myelin-associated 
proteins such as P0 and MBP by Schwann cells (Melcangi et al., 1998). These 
data are supported by our microarray studies of the distal stump of aged animals, 
where we observe a decrease in the number of myelin-associated transcripts 
(see Chapter 2).  
 
Another broad physiological change of importance to the PNS is at the level of 
the neuromuscular junction (NMJ). A recent study demonstrated that after sciatic 
nerve transection, NMJ fragmentation and loss of motor end plate area were 
more severe in aged, but not young rats (Apel et al., 2009). It has also been 
suggested that the incidence of abnormal muscle reinnervation is greater in old 
mice after sciatic nerve crush (Kawabuchi et al., 1998).  
 
Even in steady-state conditions, it has been nicely shown that NMJs of aged 
mice undergo significant structural alterations such as sprouting aberrations and 
fragmentation (Valdez et al., 2010). This represents one possible explanation for 
the motor defects and muscle atrophy well documented in aged animals. 
Interestingly, the same study demonstrated that caloric restriction and exercise 
are capable of attenuating or even reversing age-associated pathology (Valdez 
et al., 2010).   
 
Importantly, it has also been demonstrated that the rate of axonal transport 
decreases with age, suggesting that the transport of essential factors to newly 
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regenerating axons be slower or compromised (Stromska and Ochs, 1982). In 
addition, this potentially makes maintenance of axons at a long distance from the 
cell body difficult. Finally, It has also been found that the expression of nerve 
growth factor receptors, such as TrkA and p75, decreases with aging (Parhad et 
al., 1995). This could lead to less uptake of growth factors, impairing cell health 
and regeneration. This in conjunction with the decreased expression of growth 
factors themselves from Schwann cells (see Chapter 2) may have doubly 
significant consequences on neuronal cell health.  
 
These functional and structural changes in the PNS do result in clinical problems, 
even in the absence of nerve injury. Of particular significance in the aging PNS is 
small fiber neuropathy, which typically presents as pain in the feet in persons 
over the age of 60 (Lacomis, 2002). In general, peripheral neuropathies are 
frequent in the elderly, with some estimates suggesting that as high as 1 in 3 
persons over the age of 65 suffer from some form of it, most of which are 
considered idiopathic in nature (Cho et al., 2006). Thus, understanding how the 
PNS ages should have important bearing on the treatment of neuropathies.  
 
Aging and Peripheral Regeneration 
 
The modern clinical study of peripheral nerve regeneration was, like so many 
other pressing scientific endeavors, born as a consequence of violence. During 
and after the first and second World Wars, when large numbers of soldiers 
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received peripheral nerve traumas from gunshot wounds and shrapnel injuries, it 
was observed that optimal functional recovery was rarely achieved. Fundamental 
work was then undertaken to determine basic information, such as the rate of 
axonal regeneration, and the factors that influence the course of recovery 
(Gutmann, 1942; Gutmann and Guttmann, 1942; Sunderland, 1952; Woodhall B, 
1956). Although these early studies often speculated about the age of the patient 
as a clinical factor, the relatively age-homogenous population of soldiers 
prevented any clear correlations from being drawn.  
 
Still, contemporary clinical data continues to indicate that age is an important 
predictor of the functional outcome following peripheral nerve injury (Lundborg 
and Rosen, 2001; Nagano, 1998). Indeed, that age impairs axonal regeneration 
after nerve injury appears to be a conserved process, being observed in mice, 
rats, zebra fish (Vaughan, 1992; Verdu et al., 2000; Wada et al., 2013) and even 
the nematode worm C. elegans (see Appendix). Despite this widespread 
finding, the mechanisms underlying this decline have remained largely 
unexplored.  
       
One notable early study used histological based methods (mostly electron 
microscopy) to show that Wallerian degeneration, myelin clearance and the 
appearance of newly regenerating axons were all slower in rats after facial nerve 
crush (Vaughan, 1992). The same study also found that aged rats regrew fewer 
total axons after injury. In the same vein, other studies have used histological 
 34 
methods in mice to suggest that aged animals regenerate fewer myelinated 
axons after sciatic nerve injury (Tanaka and Webster, 1991; Tanaka et al., 1992). 
Although functional recovery has not been directly assessed in animal models, 
one report did note an observational delay in the resumption of "whisking 
behavior" after facial nerve injury to aged rats (Vaughan, 1992).   
 
The role of aging non-neuronal cells in peripheral nerve regeneration has also 
not been addressed. As Wallerian degeneration appears to be delayed in aged 
animals (Tanaka and Webster, 1991; Vaughan, 1992), it has been suggested 
that Schwann cell and macrophage responses may diminish with aging, but 
these results could equally be the product of axonal-protective mechanisms. 
While scarce, direct evidence of Schwann cell dysfunction with normal aging 
includes a reduction of Schwann cell proliferation in the nerve after injury 
(Komiyama and Suzuki, 1991), as well as reduced proliferation in vitro 
(Komiyama and Suzuki, 1992). More recently, a large gene-expression survey 
found similarities with steady-state Schwann cells in aged animals and the 
expression signatures of disease models of demyelinating diseases, 
predominantly finding differences in lipid metabolism and expression of immune-
related genes (Verdier et al., 2012). Finally, a paper using time-lapse imaging of 
axonal regeneration in mice in vivo showed that the rate of regeneration in aged 
animals was unaltered, but ran into "road blocks" that likely represented 
Schwann cells (Kang and Lichtman, 2013). Taken together, surprisingly little is 
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known about the mechanisms leading to decreased neuronal regeneration in 
aging.  
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CHAPTER TWO 
 
 
 
 
 
 
 
 
DIMINISHED SCHWANN CELL REPAIR RESPONSES UNDERLIE AGE-
ASSOCIATED IMPAIRMENT IN AXONAL REGENERATION 
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Forward 
 
This Chapter is a slightly modified version of a manuscript currently being 
resubmitted to  Neuron after revisions to deal with reviewer comments. While I 
have participated in several projects during the course of my PhD, understanding 
how the peripheral nervous system ages, and in particular, why neuronal 
regeneration is impaired as a result of aging, has been the central topic of my 
thesis work.  
 
Contributions 
 
The overall idea for this project came as a kind of marriage between two of my 
rotations, one with Amy Wagers and the other with Clifford Woolf. In Amy's lab I 
learned about aging and strategies for rejuvenating aging such as through 
parabiosis. An obvious question to ask upon joining Clifford's lab, then, was how 
does aging affect axonal regeneration, a key topic of study in the Woolf Lab. 
Subsequent experimental design was carried out by myself, Clifford and also in 
conjunction with Takao Omura, who served as my "day-to-day" advisor in the lab. 
The paper itself was written primarily by myself and by Clifford, with meaningful 
contribution from Amy Wagers.  
 
Technically speaking, although I directly participated in every experiment 
included in this version of the manuscript, I of course had a great deal of help, 
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from both members of my lab and outside. In particular, I frequently worked 
alongside Takao Omura, who showed me most of the basic skills in the lab, such 
as sciatic nerve crush and DRG dissection and culture, and helped tremendously 
in getting early experiments up and running quickly, including performing sciatic 
nerve crush on the first cohort of animals and often working in parallel with me. 
Takao's technical expertise was also instrumental for several experiments, and 
without him surely they would not have been accomplished: the nerve grafts 
surgeries could only have been from his hands. Amanda Brosius-Lutz in the 
Barres lab at Stanford made essential contributions in both the design and 
execution of key Schwann cell experiments, including the imaging and 
quantification of myelin, macrophage influx into the nerve and Schwann cell de-
differentiation. Inge Cheng performed key c-Jun Western Blot analyses. Christine 
Miller was the point person in performing parabiosis surgeries. Others listed as 
authors also made either intellectual or technical contributions to this manuscript.  
 
Overall, it has been a great pleasure of my PhD to be able to work with so many 
wonderful collaborators, and I certainly would not have accomplished this thesis 
without their help, and they deserve immense credit.  
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Rejuvenating axonal regeneration in aged mice. 
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SUMMARY 
 
The regenerative capacity of the peripheral nervous system (PNS) declines 
with age. Why this occurs and whether it can be reversed, however, 
remains unknown. Here, we demonstrate that 24-month old mice exhibit an 
impairment of functional recovery after nerve injury compared to 2-month 
old animals. Surprisingly, we find no difference in the intrinsic growth 
capacity between aged and young sensory neurons in vitro, nor in their 
ability to activate growth-associated transcriptional programs after injury. 
Instead, functional recovery in aged animals can be fully restored by 
transplantation of young nerve grafts. Conversely, aged nerve grafts 
diminish axonal regeneration in young hosts. Molecular interrogation of the 
sciatic nerve reveals that aged Schwann cells (SCs) fail to efficiently and 
rapidly activate a transcriptional repair program after injury, including a 
delay in the up-regulation of c-Jun protein. Functionally, aged SCs exhibit 
impaired de-differentiation and myelin phagocytosis. These results suggest 
that the age-associated decline in axonal regeneration results from 
diminished Schwann cell plasticity after denervation.  
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INTRODUCTION 
 
Successful regeneration of the PNS requires the coordinated activity of several 
distinct yet interlocking systems. After axonal injury, neurons activate 
transcriptional "intrinsic growth" programs and begin extending new axons. 
Schwann cells (SCs) in the distal nerve undergo a rapid reprogramming process, 
de-differentiating into non-myelinating repair cells that secrete pro-regenerative 
factors, uptake non-permissive myelin, recruit macrophages and create physical 
tracks onto which newly growing axons can navigate. Macrophages, in turn, 
enter the site of nerve injury from the circulation and help to clear myelin and 
axonal-derived debris, obstacles to regrowth. Remarkably, these complex 
intrinsic and extrinsic processes can lead to restoration of function after 
peripheral nerve trauma.   
 
As with most mammalian tissues, however, the regenerative capacity of the PNS 
declines with advancing age (Nagano, 1998; Pestronk et al., 1980; Tanaka and 
Webster, 1991; Vaughan, 1992; Verdu et al., 2000; Woodhall B, 1956). This 
decline has been recognized in humans since at least World War II, when follow-
up studies of patients suffering from peripheral nerve traumas demonstrated a 
correlation between age and the extent of functional recovery (Woodhall B, 
1956). This correlation continues to be observed in clinics today, such as in the 
case of brachial plexus injuries (Nagano, 1998). In addition, broader defects of 
the aging PNS have also been widely noted. For example, it is estimated that 
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nearly 1 in 3 persons over the age of 65 suffer from some form of peripheral 
neuropathy, and the underlying cause in the majority of these instances is 
considered idiopathic (Cho et al., 2006). Thus, understanding how the PNS 
changes with normal aging is of significant clinical importance. 
 
To some degree, these clinical associations between age and the extent of 
neuronal regeneration have been recapitulated in animal models. While not 
addressing functional recovery directly, early work demonstrated an age-
associated impairment of axonal regeneration in both mice and rats through 
histological assessments (Verdu et al., 2000). More recently, the developmental 
decline in axonal regeneration that is found in the nematode worm C. elegans 
was shown to be the result of neuronal-intrinsic alterations (Zou et al., 2013). In 
the case of mammals, however, to what degree age-associated impairment of 
axonal regeneration represents neuronal-intrinsic alterations versus 
environmental perturbations remains an open and critical question, with both 
mechanisms having been previously speculated about and with significantly 
different therapeutic implications.   
 
In this study, we use 24-month and 2-month old mice along with standard models 
of peripheral nerve injury to assess the potential contributions of neurons, 
immune cells and peripheral glia to the aging phenotype. Surprisingly, our results 
demonstrate that extrinsic factors are sufficient to rejuvenate the age-associated 
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decline in mammalian axonal regeneration, and broadly reveal how Schwann cell 
function and its response to axonal injury alters during normal aging.  
 
RESULTS 
 
Although previous studies have established in rodents that fewer axons 
regenerate after injury in aged animals, it is unclear how this might translate into 
functional recovery, a meaningful clinical parameter. We thus first sought to 
establish whether aging impaired functional recovery in mice after nerve injury. 
To accomplish this, we performed a sciatic nerve crush injury (a model in which 
full recovery is expected (Ma et al., 2011)) on cohorts of 2, 12, and 24-month old 
C57BL/6 mice, and assayed their sensory and motor functional recovery over 
time, using behavioral-based assays (see methods). In young animals, full 
sensory recovery is achieved approximately 15 days after injury, while motor 
function is restored by day 30. Aging, however, produces a progressive defect in 
the onset and time to restoration of motor and sensory function, with an 
approximately 3-4 day difference in full recovery between young and aged 
animals for sensory function and a 9-10 day delay for recovery of motor function 
(Figures 2.1A, 2.1B, 2.2A, 2.2B). Middle-aged animals (12-month) show an 
intermediary phenotype, indicating that age-dependent slowing of functional 
recovery is acquired gradually throughout life.  
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Figure 2.1: Progressive, age-dependent deficit in peripheral 
nerve regeneration. Cohorts of 2, 12 and 24-month old mice 
were subjected to sciatic nerve crush injury and restoration of 
sensory (A) and motor (B) function, assayed through pinprick 
and toe-spreading assays, respectively. Mean ± SEM, n = 7-8 
mice per cohort. 
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Figure 2.2: Age-dependent delay in functional recovery after nerve injury.  
Cohorts of 2, 12 and 24-month old mice from were subjected to sciatic nerve crush 
injury and the first day in which a positive sensory (A) or motor (B) behavioral 
response was recorded. *P < 0.05; **P < 0.01 in one-way ANOVA with Bonfer-
roni's multiple comparisons test. 
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What is responsible for this defect? Because axonal regeneration in mammals is 
driven by the transcriptional activation of neuronal "intrinsic growth" programs 
after injury (Chen et al., 2007; Seijffers et al., 2007), it has been widely assumed 
that the age-related decline in regeneration is the consequence of a diminished 
intrinsic growth potential of aged neurons (Pestronk et al., 1980). Unexpectedly, 
however, transcriptional profiling from young (2-month) and aged (24-month) 
dorsal root ganglia (DRGs), both before and after nerve injury, revealed 
extremely comparable gene-expression signatures, with similar levels of injury-
induced transcriptional activation between young and old ages (Figures 2.3A, 
2.3B, 2.4A). After nerve injury, over 250 genes in the DRG are up or down-
regulated greater than 2-Fold compared to naive controls (Figure 2.4B). Among 
these, only 14 are differentially expressed (> 2-Fold) between young and aged 
animals. Many of these age-variant transcripts are also de-regulated in naive 
(uninjured) conditions, implying they are part of a "background" aging signature 
and not specific to nerve injury (Table S1). Important "regeneration-associated 
genes" such as ATF3, GAP43, and Sprr1a, were not differentially expressed 
between young and aged DRGs (Figure 2.3B) (Bonilla et al., 2002; Chong et al., 
1994; Seijffers et al., 2007). As predicted from the transcriptional data, in vitro 
neurite outgrowth assays revealed comparable growth potential regardless of 
age in both naive and pre-conditioned DRG sensory neurons, confirming  no 
deficit with age in the intrinsic neuronal growth induced by injury (Figure 2.3C-
G). These experiments strongly argue that a mechanism extrinsic to neurons 
influences the regenerative potential of aging DRG neurons in vivo.  
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Figure 2.3: Neuronal intrinsic growth responses to injury remain robust throughout life. 
(A and B) Microarray data from DRG neurons. Expression vs. expression of young vs. aged 
DRGs in (A) naive conditions and (B) 4 days after nerve crush injury. Known markers of regen-
eration are highlighted in red. Lines in blue represent Fold Change = 2, blue numbers in each 
corner represent the number of genes over- or under-expressed by more than 2-Fold. (C to G) 
In vitro neurite outgrowth assays of DRG sensory neurons. Sensory neurons from naive young 
(C) or aged (D) DRGs from aged or young animals were purified and cultured for 17 hours and 
neurite outgrowth measured with Neuromath (E). Mean ± SEM, n = 3 independent experi-
ments per group, NS = not significant with unpaired t-test, Welsh's correction, two-tailed. DRG 
sensory neurons from young (F) or aged (G) animals were purified 4 days after nerve injury, 
and cultured for 12 hours, revealing robust pre-conditioning responses. 
47
Young injured vs young naive (FC) 
Old
Ag
ed
 in
jur
ed
 vs
 a
ge
d 
na
ive
 (F
C)
 
1 10 20 30
1
10
20
30
A
ATF3
SPRR1A
GAL
Ag
ed
 in
jur
ed
 D
RG
Aged naive DRG
200 1000 10000
200
1000
10000
B
203
50
GAP43
GAL
ATF3
SPRR1AGAP43
JUN
JUN
Figure 2.4: Transcriptional profiles of young and aged DRGs are comparable. 
Gene-expression data of young and aged DRG neurons. (A) Fold Change vs. Fold Change plot. 
Genes along the black y=x line represent equal Fold Change between naive and injured conditions of 
either age. Note the vast majority of genes fall roughly along this line. Several genes along the y=1 line 
that are seem to be activated only in young animals represent spurious muscle contamination (MYL1, 
TNNI2, ATP2A1, TNNC2, ACTA1) with t-test p-values well above 0.4. Red = known regeneration-
associated genes. (B) Expression vs. expression plot of aged naive vs. aged injured DRGs. Note the 
 injury response is robust. Several known regeneration markers are highlighted in red. Blue lines repr-
sent Fold Change = 2, blue numbers in each corner represent the number of genes up or down-
regulated by Fold Change of 2.4
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As such, we hypothesized that allowing "aged" axons to regenerate in a 
"youthful" environment might enhance functional recovery in aged animals. 
Conversely, we conjectured that forcing young axons to regenerate in an "aged" 
environment would result in impaired recovery. To test this, we harvested 1 cm 
segments of sciatic nerve from either aged or young animals and directly sutured 
them into the sciatic nerves of either old or young animals. In this way, axons 
from the host animal must regenerate through a 1 cm segment of either age-
matched or age-mismatched nerve tissue before reaching their targets in the skin 
(Figure 2.5A). We assessed sensory functional recovery to monitor 
regeneration. Because transection/re-suture injuries are more severe than crush 
injuries, motor recovery of plantar muscles in the foot is not obtained, and 
functional sensory recovery takes much longer (Ma et al., 2011). Strikingly, we 
observed that functional recovery was enhanced in aged animals receiving 
young nerve grafts such that it matched young animals receiving young nerve 
grafts (Figure 2.5B). Reciprocally, young animals receiving aged nerve grafts 
showed slower functional recovery, similar to aged animals receiving aged nerve 
grafts (Figure 2.5B).  
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Figure 2.5: Neuronal-extrinsic factors are sufficient to recapitulate or rejuvenate the phenotype. 
(A) Schematic of nerve graft strategy. 1 cm long segments from young or aged animals were sutured 
into the nerves of either young or aged host animals and restoration of sensory recovery assayed as in 
Fig. 1. (B) Time-course of sensory recovery as measured by pinprick score. (C) Schematic of Thy1 
YFP+ graft strategy. 1 cm long segments of sciatic nerves from either aged or young mice were sutured 
onto the sciatic nerves of young Thy1 YFP+ host animals and nerves analyzed histologically after 7 days 
(D). Representative images of YFP+ axons in the donor aged and young nerve grafts, 5mm distal to the 
site of suture. (E) Quantification of the number of YFP+ fibers at each specified distance from the suture 
site. Axons counts were quantified using ImageJ. Mean ± SEM is plotted, n = 7 mice per group (one 
mouse with counts greater than 3 SD from the mean was removed from the dataset), *P <0.05, **P 
<0.01 with unpaired t-test, Holm-Sidak correction. 
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We further quantified the extent of axonal regeneration in an age-mismatched 
system. To accomplish this, we used a nerve graft strategy in which either young 
or old 1 cm long pieces of sciatic nerve were sutured onto the nerves of Thy1 
YFP+ young host animals (aged transgenic mice were not available for the 
reciprocal experiment) (Figure 2.5C). Thy1 YFP+ mice were chosen to enable 
visualization of regenerating fibers in the graft. After one week, the number of 
YFP+ axons growing into either young or aged donor tissue was quantified 
histologically. Forcing young axons to regenerate into an aged environment, as 
opposed to a young one, severely impaired the extent and length of growth with 
reduced numbers of axons at every distance from the site of the graft (Figure 
2.5D and 2.5E).  
 
We next sought to identify what age-associated changes occur within the sciatic 
nerve environment. Transcriptional profiling of young and aged nerves distal to a 
sciatic nerve ligation (to prevent regenerating axons from contaminating 
samples) revealed widespread age-related alterations (Figure 2.6A, 2.7A, 2.7B, 
Table S2, Table S3). This can be seen most prominently by the number of 
transcripts that deviate from the Y=X parity line in the fold change versus fold 
change plot, indicating that hundreds of genes up- or down-regulated after injury 
in the young are not equally regulated in aged nerves. Strikingly, we found that 
many of these genes are associated with a "repair program" in Schwann cells 
(SCs) activated after injury (Figure 2.6A, Table S3). After nerve injury, SCs 
undergo a phenotypic reprogramming process whereby they down-regulate their 
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myelinating phenotype, rapidly divide, and acquire a non-myelinating, "repair cell" 
phenotype critical for the development of a growth permissive environment within 
the nerve that facilitates regeneration (Arthur-Farraj et al., 2012; Mirsky et al., 
2008).  
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Figure 2.6: Acquisition of repair cell phenotype is impaired in aged 
Schwann cells.  
(A) Expression data from the distal nerve stump of aged and young animals after 
nerve transection/ligation injury. X axis represents Fold Change of young injured 
against young naive transcripts. Y axis is Fold Change of aged injured against 
aged naive transcripts. Transcripts along the black y=x line represent equal up or 
down regulation after injury compared to naive. Red = myelin-associated genes; 
Blue=growth factors-associated; Orange=mitosis-associated. (B) Representative 
Western blot analysis of total c-Jun. Cross-sections and whole mounts of sciatic 
nerves from aged and young animals at day 0, 3, 5 and 7 after nerve crush injury 
stained with (C) S100 and p75, (E) MBP, and (G) CD68. (D, F and H) 
Quantification of staining from (C, E and G). Mean ± SEM is plotted, n = 3-4 mice 
per group, *P < 0.05, **P < 0.01 with unpaired t-test, Holm-Sidak correction.  
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Figure 2.6 (cont): Acquisition of repair cell phenotype is impaired in aged Schwann cells
0 3 5 7
0
25
50
75
100
Young
Aged
%
p7
5+
SC
s
0 3 5 7
0
5
10
15
20
25
int
er
na
liz
ed
m
ye
lin
/to
ta
la
re
a
(%
)
yo
un
g
ag
ed
day 0 3 5 7
                           -  1   2   3   5  7 10 
Young Old
  -   1   2  3   5   7  10
GAPDH 40
(KD)
C D
A
B
S100
p75
Total c-Jun
40
55
E F
0 3 5 7
0
6
12
yo
un
g
ag
ed
yo
un
g
ag
ed
Day after injury
Day after injury
Day after injury
CD
68
+
ar
ea
/to
ta
la
re
a
(%
)
**
**
**
p = 0.07
*
A
FC young injured vs young naive (distal stump)
G H
FC
 a
ge
d 
inj
ur
ed
 vs
 a
ge
d 
na
ive
 (d
ist
al 
stu
m
p)
PBK
CDC20
KIF2C
BIRC5
HIST1H2AK
50um
20um
CD68
100um
54
NGFR
PMP2
MPZ
PRX
CLDN11
PMP22
NOTCH4
MAL
EGR2
ATF3
100
100
1000
1000
10000
10000
Expression young injured
Ex
pr
es
sio
n 
ag
ed
 in
jur
ed
PMP2 MAG
MAL
PRX
MPZ
MBP
PMP22
EGR2
NGFR
100 1000 10000
100
1000
10000
Expression young naive
Ex
pr
es
sio
n 
ag
ed
 n
aiv
e
A B
Figure 2.7: Transcriptional alterations in aged Schwann cells.  
(A) Expression vs. expression of naive aged vs. young nerves is plotted. In red, sev-
eral SC-associated transcripts are highlighted. Note the expression of myelin-related 
genes is down-regulated in aged animals under steady state conditions. (B) Expres-
sion vs. expression of injured aged vs. young nerves (day 4 after sciatic nerve crush). 
Select SC-associated genes are highlighted in red. 
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We observed a prominent age-related deregulation of genes encoding key repair 
cell functions. Genes down-regulated in aged nerves relative to young ones after 
injury included those associated with growth factors (BTC, NGFR, BDNF) and 
mitosis (e.g. KIF2C, PBK, BIRC5, CDC20) (Figure 2.6A, Table S3). Likewise, 
genes associated with myelin production (e.g. PMP2, MPZ, MAL, EGR2) were 
relatively over-expressed in lesioned aged animals, implying an impaired ability 
to down-regulate their myelinating phenotype after injury (Figure 2.6A).  
 
Recently, the transcription factor c-Jun was identified as a "master regulator" of 
the SC repair phenotype after nerve injury, and SC-specific ablation of c-Jun 
results in severely impaired functional recovery (Arthur-Farraj et al., 2012). 
Interestingly, we noticed marked similarities between the transcriptional profiles 
of injured aged nerves and genes  altered in mice lacking c-Jun expression in 
SCs after injury (e.g. MPZ, CDH1, SEMA4F) suggesting that genes under control 
of c-Jun were altered in aged animals (Arthur-Farraj et al., 2012). Strikingly, 
Western blot analysis demonstrated that the regulation of c-Jun protein was 
significantly altered in the nerves of aged animals immediately after injury 
(Figures 2.6B and 2.8). This initial burst of c-Jun expression in the nerves of 
young animals 1 day after injury was approximately 5-fold higher than in aged 
animals (Figure 2.8). ERK and JNK, two upstream kinase pathways of c-Jun, 
were unaltered in aged sciatic nerves after injury (Figure 2.9).  
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Figure 2.8: Early c-Jun deregulation in aged nerves after injury.
(A) Summary of Western blot analyses of c-Jun regulation in young 
and aged nerves (distal to the site of injury) after nerve injury. n = 3 
biological replicates for all time-points except day 7, where n = 2. **P < 
0.01 with unpaired t-test, Holm-Sidak correction.
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nerves. (A) Representative Western blot analysis of 
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Given that aged SCs are unable to activate transcriptional repair programs after 
nerve injury, one would predict functional consequences in the SCs, and more 
generally, for Wallerian degeneration in the nerve. As predicted, expression of 
p75, a marker for the repair cell phenotype was delayed in aged SCs after sciatic 
nerve crush injury compared to young controls. In young animals, ~65% of 
S100+ SCs were positive for p75 3 days after nerve injury (Figures 2.6C and 
2.6D). S100 is a SC marker present in intact and dedifferentiated SCs. In aged 
animals, however, p75 reactivity in only ~16% of S100+ SCs was observed.  
 
A key downstream function of SCs after injury is the intracellular accumulation 
and sequestration of myelin from their cell membrane. Myelin is an inhibitory 
substrate for axon growth, and it is thus essential for external myelin to be 
cleared from the distal injury site before regeneration can occur (McKerracher et 
al., 1994). SCs from aged mice showed a deficit in their ability to sequester and 
uptake myelin during early time points after injury, in parallel with the delayed 
expression of p75 (Figures 2.6E and 2.6F). Dense MBP positive myelin 
accumulations were localized within p75 positive (dedifferentiated) SCs soon 
after injury in young nerves but not in p75 positive aged SCs. The defect can be 
clearly seen from myelin staining in distal segments of the sciatic nerve after 
crush injury, where 3 days after injury SCs in young nerves show bright and 
punctate myelin staining, indicating that myelin is being internalized and cleared, 
while in aged animals myelin staining is diffuse along axon segments as in intact 
nerves. 
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Macrophages are required for axonal regeneration to remove axonal debris as 
well as any remaining myelin not removed by SCs, and macrophage recruitment 
into the degenerating nerve is dependent upon factors secreted by de-
differentiated SCs (Barrette et al., 2008; Napoli et al., 2012). We thus measured 
macrophage recruitment into the degenerating nerve by tracking the expression 
of CD68, a standard marker for activated macrophages, over time. This revealed 
a markedly delayed recruitment of CD68+ macrophages for up to 7 days after 
injury in aged animals (Figures 2.6G and 2.6H).  
 
In addition, we also wondered whether restoration of "young" circulating factors 
in aged animals might partially reverse the diminished functional recovery 
observed in 24-month old animals. To address this question, we performed 
heterochronic parabiosis, in which aged and young animals are surgically 
conjoined such that their circulatory systems are shared. This method was 
recently used to successfully reverse an age-associated defect in re-myelination 
of the nervous system driven by macrophage dysfunction (Ruckh et al., 2012). 
After thirty days of parabiosis to allow for proper chimerism between animals we 
performed sciatic nerve crush injury on the aged partner and followed the 
restoration of sensory and motor function every day for ~45 days using 
behavioral assays as earlier (Fig 1). Unfortunately, all old:old control pairs died 
before the completion of the experiment. As shown in Figures 2.10A-2.10D, 
however, exposure of "youthful" systemic factors did not affect the regenerative 
phenotype of aged animals, with the difference in recovery rates being very 
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comparable to aged and young animals in the absence of parabiosis (Fig. 1). 
Again, as parabiosis has been demonstrated to rejuvenate age-associated 
defects in a variety of paradigms these results were not expected and suggested 
to us that intrinsic defects in circulating factors were not likely to be driving age-
related defects in regeneration.  
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Figure 2.10: Parabiosis does not affect regeneration in aged animals.  
(A) For parabiosis experiments, congenic mouse strains were used (one partner CD45.1+ 
and one partner CD45.2+). Chimerism of blood cells was thus evaluated by flow cytometry 
after parabiosis by evaluating the percentage of donor blood within spleens of the host 
animal. Plots are presented as mean ± SEM, n = 4 mice for each congenic strain. (B) Sche-
matic of parabiosis experiment. Young:young and aged:young pairs were surgically con-
joined for thirty days to allow for chimerism and then subjected to sciatic nerve crush. Resto-
ration of functional recovery in the injured partner was assessed through pinprick (C) and 
toe-spreading (D) as in Fig. 1. Mean ± SEM, n = 7 per cohort to begin (1 young:young pair 
died at day 17, another died at day 21, 1 old:young pair died at day 39, 2 others at day 45).
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DISCUSSION 
 
Our work presents several interesting findings. First, we show that aging 
introduces a progressive decline in axonal regeneration after injury in mammals, 
akin to work done in C. elegans and mirroring human clinical data. Given that in 
mice, as in humans, a critical period is observed in which functional motor 
recovery will not be obtained without timely target re-innervation (Ma et al., 
2011), this slowing in regenerative potential suggests an age-dependent 
mechanism that may contribute to suboptimal clinical outcomes after nerve 
trauma in elderly individuals.  
 
Furthermore, our data also demonstrate that the regenerative capacity of the 
aging mammalian PNS is not limited by neuronal responses as previously 
assumed, but is profoundly influenced by extrinsic factors emanating from the 
surrounding tissue. Unexpectedly, we found that neuronal intrinsic growth 
responses are unaltered with normal aging, indicating that aged neurons can be 
fully "primed" to regenerate after an axonal injury. We further demonstrated that 
the ectopic introduction of aged tissue could impede regeneration in young, 
healthy mice, whereas grafting of young tissue liberated aged neurons to express 
their full, robust repair potential. These observations indicate that deficient axonal 
regeneration in aged animals arises from dominant, extrinsic inhibition of 
neuronal outgrowth by the aged microenvironment and suggest that functional 
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recovery after axotomy may be enhanced throughout life via neuron-extrinsic 
mechanisms.  
 
Our analysis demonstrates that SC injury responses are substantially altered in 
aged animals, suggesting a failure of aged SCs to effectively activate an 
appropriate transcriptional repair response. These data implicate aged SCs as 
key mediators of age-dependent inhibition of axon regeneration in the PNS. 
Although it remains to be determined whether the altered SCs responses of aged 
animals result entirely from intrinsic defects (age-acquired DNA damage, e.g.) or 
whether this represents a failure in an upstream signaling cascade (e.g. leading 
to delayed c-Jun expression), it is clear that the failure of aged SCs to efficiently 
acquire a repair phenotype after nerve injury would impinge on axonal 
regeneration. In the future, it will be of great interest to determine both the exact 
cause for these alterations in the SC compartment and whether they contribute to 
other age-associated disorder of the PNS, such as peripheral neuropathy. 
 
It is interesting to note that SCs are potentially unique among adult, differentiated 
cells in that, after injury, they undergo a phenotypic reprogramming process that 
resembles trans-differentiation (Arthur-Farraj et al., 2012) and acquire a de-
differentiated highly proliferative almost stem cell like state. Given the well-known 
alterations that occur in stem-cell compartments during normal aging, it is 
perhaps not surprising that SCs, which undergo major transcriptional and 
phenotypic changes after injury, are relatively vulnerable to age-acquired 
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alterations. Similarly, glial cells in the central nervous system also exhibit an age-
associated decline in function. For example, the differentiation potential of 
oligodendrocyte progenitor cells declines with age, resulting in decreased 
myelination (Shen et al., 2008). Unlike what we observed with SCs, however, this 
diminished function in CNS glia results in part from extrinsic signaling via 
hematopoietic cells (Ruckh et al., 2012).  
 
Finally, our data may have bearing on therapeutic strategies for promoting neural 
repair in aged patients, where replication of a youthful extrinsic environment 
should be conducive to greater recovery. Although rare, limb transplants are now 
successfully performed and our work would suggest that the age of the donor 
may influence outcomes.   
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EXPERIMENTAL PROCEDURES 
 
Methods 
 
Mice. 
Young (8-12 week old) and aged (24-26 month old) C57/BL6 mice were obtained 
from Charles River and the National Institute of Aging (NIA), respectively. Thy1 
YFP+ animals were bred in house, originally obtained from Jackson Labs, line # 
003709. Animals were housed and handled in accordance with protocols 
approved by the Administrative Panel on Laboratory Animal Care (APLAC) of 
Stanford University or in full accordance with the IACUC guidelines of Children’s 
Hospital Boston.  
Sciatic nerve crush. 
All surgical experiments were performed under 2.5% isoflurane on either young 
adult mice (8-12 weeks old) or aged mice (24-26 months old). Sciatic nerve crush 
injury was performed as previously described (Ma et al., 2011). Briefly, the sciatic 
nerve was exposed at mid-thigh level on the left side of the animal and crushed 
with smooth forceps for 30 seconds. For experiments involving Schwann cells 
(Fig 3): Mice were anesthetized using isoflurane. Upper thigh was shaved and 
sterilized using isopropanol. A 1 cm incision was made using a scalpel and nerve 
was visualized via blunt dissection using forceps. The left sciatic nerve was 
crushed at mid-thigh for 5 seconds using forceps marked with sterile graphite to 
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mark the crush site. Carprofen (5mg/kg subcutaneous) was administered for 
analgesia.  
 
Sciatic nerve graft. 
For Thy1 experiments, 1 cm long segments of the sciatic nerve (from mid-thigh 
level to the site of trifurcation) from either young or aged animals were acutely 
harvested and grafted using 10-0 nylon sutures onto the sciatic nerve just below 
the sciatic notch of 8 week old Thy1 YFP mice. These nerves were only sutured 
at the proximal sight and the distal side was left as a free ending. For nerve graft 
studies involving behavioral assessments, 3 mm of the sciatic nerve was 
removed from the host mice and was replaced with a 1cm long sciatic nerve graft 
of either young or aged animals. The proximal and distal ends were  sutured with 
10-0 nylon. 
Assessment of sensory recovery using a pinprick assay. 
Pinprick assay was performed as described previously (Ma et al., 2011). Briefly, 
mice were habituated on wire mesh cages for 30 minutes, until calm, and then 
tested for pain responses on the hind paw using a small insect needle. All 
experiments were repeated by at least 2 separate investigators. In the case of 
nerve graft studies, experiments were conducted blinded to the age of the donor 
graft. The person who performed the surgeries never participated in the 
behavioral experiments.  
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Assessment of motor recovery by toe-spreading test. 
Toe-spreading assay was performed as described previously (Ma et al., 2011). 
Briefly, mice were gently covered with a piece of cloth and lifted by the tail, 
uncovering the hind paws for clear observation and the number of toes and 
extend of toe-spreading was measured for the injured side and compared to the 
uninjured paw. Again, at least two separate investigators made independent 
assessments for each experiment. Nerve graft studies were completed blind to 
age of donor graft and the surgeon did not participate in behavioral studies.  
Microarray analysis. 
Common pools of RNA were derived from ipsi- (injured) and contralateral 
(uninjured) L4 and L5 DRGs or ipsi- and contralateral sciatic nerves (1cm long 
segments distal to the site of injury), amplified, and hybridized to Illumina 
beadchip arrays. All microarray experiments were conducted in biological 
triplicates, except for the DRGs from old naive animals, which were done in 
duplicate. Each replicate was composed of tissue from at least 2 separate 
animals. All analyses were carried out either in Excel or in GenePattern 
(www.genepattern.org) using the Multiplot module.  
 
Quantification of neurite outgrowth.  
DRG sensory neurons were purified as described previously (Costigan et al., 
1998). 1,500-2,000 cells were plated on laminin and fixed 17 hours after plating 
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(for naive) or 12 hours after plating (for pre-conditioned). Quantification was 
completed using Neuromath as described previously (Ma et al., 2011). 
Quantification was completed blind to age or condition and repeated three 
separate times.  
 
Parabiosis. 
 
Parabiotic pairs were joined as previously described (Ruckh et al., 2012). All 
animals used for parabiotic pairings were male, from congenic strains to avoid 
immune rejection between the partners. Parabiotic pairings included isochronic-
young pairs (two young mice joined, each 8 weeks old), isochronic-old pairs (two 
old mice joined, each 24 months old -- all died) and heterochronic pairs (a young 
mouse joined to an old one, respective ages same as above). 
 
Statistics. 
All statistics were completed in GraphPad Prism version 6 for Macintosh.  
 
Western Immunoblotting 
Sciatic nerves were dissected from young and old mice at indicated days after 
sciatic nerve injury. Protein lysates from sciatic nerve were extracted in the 
presence of a protease cocktail tablet (Roche Diagnostics) using RIPA extraction 
buffer by homogenizer and cell debris was removed by centrifugation (4°C, 
15min). Protein concentrations were determined by using BCA protein assay kit 
(Pierce). Equivalent amounts of protein were loaded and separated by SDS-
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PAGE and subsequently transfer to an Immobilon-P PVDF transfer membrane 
(Millipore). After washing in TBS containing Tween-20, blots were blocked in 5% 
milk for 1h at room temperature and incubated with rabbit polyclonal antibodies 
against p-ERK (Cell Signaling, 1:500), total ERK (Sigma, 1:1000), p-JNK (Cell 
Signaling, 1:500), total JNK (Cell Signaling, 1:500), ATF3 (Santa Cruz, 1:500), 
total c-Jun (Cell Signaling, 1:500), and a mouse monoclonal antibody against 
GAPDH (Chemicon, 1:2000). HRP-conjugated secondary antibody (anti-rabbit, 
anti-mouse, Pierce, 1:5000), an ECL kit (Pierce) and autoradiography film 
(Genesee Scientific) were used following the manufacturer’s protocol for signal 
detection.   
 
Immunohistochemistry:  
Sciatic nerves were harvested distal to crush by perfusing mice with ice cold PBS 
followed by cold 4% paraformaldehyde. Nerves were postfixed for 5 hours at 
4°C. For myelin staining, epineurium was carefully removed and axon bundles 
were separated along natural divisions using forceps. 3-4 small (~3mm) 
segments of these bundles were cut at approximately the location of the nerve 
trifurcation. Segments were permeabilized in ice-cold methanol for 20 minutes 
and rinsed 3x10 minutes in blocking buffer (10% normal donkey serum,1%Triton 
X-100 in PBS) at room temperature (RT). Nerve bundle staining: Briefly, 
segments were blocked in blocking buffer overnight at 4°C. Segments were 
incubated in primary antibodies: goat anti p75 (Neuromics,1:500), rabbit anti-
MBP (DAKO 1:100), diluted in blocking buffer at 4°C for 72 hours with rocking 
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followed by 3x10 minute washes at RT and 6x1 hour washes in blocking buffer at 
4°C. Secondary antibodies (donkey anti-goat 488, donkey anti-rabbit 563, 
donkey anti-rat 633, Invitrogen) were diluted 1:1000 in blocking buffer. Segments 
were incubated in secondary antibody for 48 hours at 4°C with rocking and rinsed 
as after primary antibody incubation followed by 3 clearing steps in 25%, 50%, 
and 75% glycerol, respectively, for 24 hours each at 4°C. Nerve bundles were 
mounted in glycerol-based Vectashield mounting media with DAPI.   
 
For staining of sciatic nerve cross-sections, post-fixed nerves were cryoprotected 
by sinking in 30% sucrose overnight.  Frozen nerves were crysosectioned into 
10-µm sections. Sections were permeabilized with ice-cold methanol for 10 
minutes and blocked in blocking buffer (10% donkey serum, 0.2% Triton X-100) 
for 1 hour at RT followed by overnight incubation in primary antibody: goat anti 
p75 (Neuromics, 1:500), rabbit anti S100 (DAKO, 1:500), rat anti CD68 (AbD 
serotec 1:1000) at 4°C. Following 3x10 minute PBS rinses at room temperature, 
slides were incubated overnight in secondary antibodies (Invitrogen, 1:1000) at 
4°C, rinsed 3x10 minutes in PBS and mounted with Vectashield plus DAPI. 
 
 
Quantification 
Quantification was performed using National Institutes of Health Image J. Images 
were acquired using Zeiss Axio Imager M1 and Axiovision software. Images were 
analyzed blind. 
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Internalized myelin quantification: Image of nerve bundle was cropped to uniform 
size and MBP signal threshold was adjusted to reveal areas of intense MBP 
accumulation. Area occupied by MBP/area of nerve in cropped image was 
determined.  
P75/S100 quantification: For each cross-section, S100 and p75 signal threshold 
was adjusted to exclude background signal. A region of interest (ROI) was 
created based on the S100 positive area of the cross section. This ROI was 
applied to the p75 image and the percent of the ROI pixels positive for p75 was 
determined.  
Thy1 YFP+ fibers quantification: Images of nerve sections from each distance 
from the suture site were taken at 10x magnification (at least 3 separate nerve 
images per animal per distance). The images were imported into ImageJ, 
converted to black and white, converted into a binary image, and the number of 
"masks" was counted for each image. This was done in exactly the same 
procedure for each image, and all images were taken with the same exposure 
time. 
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Neuronal intrinsic growth 
 
 
In the context of regeneration in general, it is intriguing to observe that DRG 
sensory neurons appear relatively unaffected by age, both functionally in terms of 
neuronal intrinsic growth, as well as transcriptionally, where very few alterations 
were seen by microarray profiling (Figure 2.3). While not included in the main 
manuscript due to the low number of animals, the slow-regeneration phenotype 
of aged animals did not appear to be rescued even by enhancing neuronal 
intrinsic growth in vivo (see Appendix). This was accomplished by testing the 
functional recovery after sciatic nerve crush injury in 2-year old hsp-27 over-
expressing mice. Hsp-27 has been demonstrated to enhance axonal 
regeneration and Western blot analysis showed continued expression of the 
construct at 2-years of age (data not show) (Ma et al., 2011).  
 
Although our data strongly suggest that a failure in neuronal intrinsic growth in 
aged animals is likely not the primary problem, it is always difficult to show 
something is not the case, and it remains possible that we have overlooked some 
subtle neuronal defect. For example, one caveat of our functional assays is that 
we essentially took "snap-shots" of neuronal growth on laminin, a permissive 
substrate. To get a sense of temporal kinetics, it would have been worthwhile to 
complete time-lapse imaging of aged and young neurons in culture, as well as to 
look for defects on other substrates, such as on the non-permissive myelin. 
Similarly, had we performed microarray profiling of aged and young DRGs at 
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various time-points of injury, it is possible we would have detected a defect early 
in the course of injury. Still, the broad picture of neuronal responses with age is 
that they remain intact.  
 
As discussed earlier in the thesis, there is ongoing debate in the field of axonal 
regeneration as to whether failure of axonal regeneration, either the CNS or the 
PNS, is truly influenced by a non-permissive environment. Although this thesis 
work does not speak to regeneration in the CNS, it does highlight the fact that a 
non-permissive environment can hinder regeneration even when intrinsic growth 
is robust or increased. Thus, while generally speaking overcoming inhibitory 
signals and enhancing intrinsic growth have been seen as two distinct 
approaches, it would be worthwhile to synergize these strategies. For example, 
one could imagine a triple deletion of PTEN, SOCS3 and PTPsigma in retinal 
ganglion cells to promote regeneration in the CNS, or simultaneously enhancing 
both ATF-3 and Schwann cell responses in the PNS.  
 
Our finding of unaltered neuronal properties with advancing age is also 
interesting in the more general context of normal aging. Given that other long-
lived post-mitotic cells are particularly susceptible to the aging process from 
factors such as oxidative stress, DNA damage and mitochondrial dysfunction 
(Geiger et al., 2013) our results imply that DRG neurons may have specific 
mechanisms for countering or preventing age-accumulated deleterious effects. 
Do DRG neurons have specialized or more active DNA repair pathways? Are 
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stress responses or protein degradation pathways more active in these cells? In 
collaboration with Amy Wagers, we attempted to assess the DNA-damage state 
of 2-year old sensory neurons and Schwann cells, however, these experiments 
failed along technical lines (purifying the cells ubiquitously caused DNA damage). 
Regardless, understanding what allows peripheral neurons to maintain 
themselves through advancing age may lead to greater insight as to how to 
maintain somatic cells in general.  
 
These issues are particularly important in the context of neurodegenerative 
disease. Thus far, it is extremely unclear how changes to neurons during normal 
aging might alter the disease progression of neurodegenerative disorders, or 
whether there are substantial changes at all. One natural extension of this work 
would be to understand how neurons age in the CNS. Although a hallmark of 
many neurodegenerative diseases is the aggregation of protein(s) within cells, it 
is often unknown whether these proteins are actually involved with disease 
progression or are simply acting as a marker. While many neurodegenerative 
diseases result in the death of neurons, it is perhaps incorrectly assumed that the 
majority of changes result from the neurons themselves. Thus, it would be 
interesting to complete neuron-specific expression profiling and/or proteomics to 
determine whether and how neurons age in the CNS, and whether they do so 
differently in the background of disease.  
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The role of macrophages 
 
In this thesis work, we also addressed the role of circulating and immune factors, 
including macrophages, in hindering axonal regeneration in aged animals. 
Although we used a parabiosis paradigm to test the role of circulating 
macrophages, there are other strategies we could have employed, such as 
performing age mis-matched bone marrow chimeras or even bone marrow 
transplants. We chose parabiosis because it is considered the least disruptive 
method for accomplishing chimerism of blood cells; however, one benefit of 
these alternative approaches is that they would have provided a nearly compete 
replacement of donor cells, perhaps better addressing the question. In particular, 
the possibility that aged macrophages exert a "negative" effect on regeneration is 
difficult to exclude in a chimeric model, as perhaps even a few aged 
macrophages are enough to impair axonal regeneration.   
 
 
In a tangential sense, these data also add fuel to the fire about the often debated 
role of macrophages in PNS regeneration. As mentioned earlier, some of the 
strongest evidence in support of key macrophage involvement in promoting PNS 
regeneration has come from studies in which myeloid cells were depleted and 
subsequent axonal regeneration was shown to be impaired, such as in Barrette 
et al. (Barrette et al., 2008). In that study, the authors demonstrated that myelin 
clearance was delayed in the sciatic nerves of animals lacking innate immune 
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cells, and suggested, as many others have, that the critical role for macrophages 
is in clearing inhibitory myelin from the site of injury.  
 
While not directly addressed in our manuscript, our data is in conflict with these 
conclusions, and further poses questions about the true function of macrophages 
in peripheral regeneration. As seen in Figure 2.6 in Chapter 2, myelin is 
undoubtedly being sequestered and engulfed by Schwann cells until at least one 
week after injury (the longest observed time-point). In fact, from our histological 
work, it appears that there is very little, if any, exogenous myelin outside of 
Schwann cells during these time points. Thus, if macrophages are indeed the 
primary myelin debris clearers after nerve injury it is extremely unclear how or 
why they are obtaining myelin. More puzzling, after 7 days, when macrophages 
are at their peak numbers, axons in the PNS are well on their way to 
regenerating, as by day 10 or 11 they have formed functional connections with 
their downstream targets in the skin (Figure 2.1), thus macrophage-dependent 
debris clearance does not appear to affect axonal regeneration at early time-
points, even though their absence is supposedly inhibitory. Do macrophages 
perhaps clear dying or dead Schwann cells themselves? Is there a deeper 
Schwann cell/macrophage interaction, either through cell-cell contact or via 
secreted factors? Clearly more careful work will need to be done to fully 
understand the role of macrophages in promoting regeneration, starting with 
detailed observations of Schwann cell and macrophage interactions. Molecular 
interrogation of macrophages within the DRG and distal stump at various time-
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points after injury in the nerve might also serve to help elucidate whether there 
are kinetic changes to macrophage phenotypes or if they secrete particular 
factors capable of impinging on regeneration.  
 
Finally, these results also underscore the differences in macrophage function 
with respect to the CNS and PNS. As mentioned earlier, the differentiation and 
myelinating potential of oligodendrocyte progenitor cells (OPCs) declines with 
advancing age (Ruckh et al., 2012). Unlike in the PNS, however, results from 
those studies indicate critical roles for macrophages in stimulating OPC 
differentiation. Furthermore, using parabiosis, the same study implies that there 
are macrophage-intrinsic defects with aging, and that these defect bear directly 
on glial cell function in the CNS.  
 
The role of Schwann cells 
 
While our work raises a number of issues related to macrophage function and 
contribution to regeneration, it also strengthens growing notions of Schwann cell 
importance. Although our data overwhelmingly provides a model in which age-
associated Schwann cell dysfunction leads to poor axonal regeneration, it is 
nonetheless difficult to completely rule out other mechanisms, such as 
differences in fibroblasts, resident macrophages or extracellular matrix cues, 
however unlikely. To this end, future experiments could potentially directly 
address the role of Schwann cells through age-mismatched Schwann cell 
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transplants. In these cases, however, it is unclear whether Schwann cells 
injected into the sciatic nerve in vivo would have the capacity to engraft or 
compete against the resident Schwann cells already occupying the niche. A 
second experiment that we attempted, which failed for technical reasons, was to 
infect aged Schwann cells in vivo with an adenovirus loaded with a c-Jun over-
expressing construct. This would have been another strategy to directly test our 
suggested molecular mechanism.  
 
How exactly do Schwann cell defects in de-differentiation lead to impaired axonal 
regeneration? The answer is likely to be contained not within one Schwann cell 
function, but many. As demonstrated in Chapter Two, there is some evidence to 
suggest that Schwann cell phagocytosis is impaired as a result of poor de-
differentiation. This evidence is supported by recently generated data showing 
that aged Schwann cell phagocytosis of myelin in vitro is also impaired (data not 
shown). Thus, impaired Schwann cell clearance of myelin may be one major 
factor.  
 
In addition, it is possible that reduced secretion of growth factors or reduction in 
the expression of inhibitory molecules also plays a role in reducing axonal 
regeneration in aged animals. In support of this view, our microarray data shows 
fewer growth factor-associated transcripts after injury in old animals (Figure 2.6). 
Although preliminary, we have also generated some data implying that Schwann 
cells can directly modify the growth potential of neurons in vitro and that the age 
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of both cell types may affect this growth (see Appendix). It will be interesting in 
the future to test the growth promoting effects of both young and aged Schwann 
cell conditioned media on neuronal cultures as well as to identify potential 
molecules involved. At least one previously uncharacterized EGF family member 
growth factor, betacellulin, comes up in our array data of the aging distal stump 
(Figure 2.6).  
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A recent study suggested that Schwann cells themselves may actually form 
physical barriers to axonal regeneration (Kang and Lichtman, 2013). One 
possible explanation of these observations is that Schwann cells in their 
myelinating state do not adequately form so-called bands of Bungner, essentially 
failing to laydown the "roads" on which newly regenerating axons can grow. 
Thus, while difficult to directly test, a failure of aged Schwann cells to de-
differentiate may result in physical impediments.  
 
Finally, as is the case with the neurons, a fundamental question that this thesis 
work poses is whether the age-associated aberrations we observe in Schwann 
cells are unique to these glia, or whether cells of the glia lineage are generally 
susceptible to age-induced dysfunction. Again, this is important in the context of 
neurodegenerative disorders, where it is not known how an aging glial 
environment might influence the course of disease progression. One particularly 
intriguing study demonstrated that wild-type neurons will die when cultured with 
glia that lack SOD1, or with mutant human SOD1, the gene responsible for many 
familial cases of amyotrophic lateral sclerosis (Di Giorgio, 2007). As superoxide 
dismutase (SOD) plays a key role in regulating oxidative stress, it is not 
farfetched to think that glia acquire dysfunction with normal aging.  
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Concluding remarks 
 
Overall, I hope that you have found this thesis as enjoyable to read as it has 
been to produce the work contained within it.  I feel this thesis work has taken an 
important step forward in understanding a basic biological question -- why does 
aging impair neuronal regeneration? -- while simultaneously using an aging 
model to examine fundamental questions about how peripheral nerve 
regeneration works.  
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APPENDIX 
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Forward 
 
 
Found here are complete rationale, descriptions and methods that are mentioned 
and tangentially relevant for the thesis, but not part of the main body of work 
(Chapter 2). They are useful additions to the introductory and discussion 
chapters.  
 
Global view of regeneration-associated genes 
 
Although various markers associated with axonal regeneration have been 
identified, I wished to explore the transcriptional profile of injured vs. naive DRG 
neurons from a genome-wide point of view. To accomplish this, I utilized 
previously generated data (Seijffers et al., 2007) and plotted the expression of 
each gene in injured DRG neurons against its corresponding expression in naive 
DRG neurons. These results visually demonstrate that several hundred genes 
are activated in the DRG upon nerve injury in a predominantly up-regulated 
fashion (Figure A1). Although we tend to think of regeneration-associated genes 
as being limited to a handful of transcription factors (ATF-3, c-Jun, Sox11) along 
with a couple of other makers (GAP-43, SPRR1A), this analysis shows that the 
injured-induced transcriptional program is widespread, being comparable to two 
completely different cell-types of the same lineage. Furthermore, this analysis 
shows the need to study regeneration-associated transcriptional programs from a 
"systems level" point of view, incorporating each gene and the potential modules 
it regulates into our mode of thinking.  
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Figure A1: Injury-induced transcriptional response in DRG neurons. 
Expression vs. expression of whole DRG transcriptomes under either steady-
state (naive) or injured (5-days after sciatic nerve crush injury) conditions. 
Microarray data used from Rhona Seijffers (Seijffers et al., 2007). Expression 
represents averages from n=3 biological replicates for both naive and injured 
DRGs.  
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Assessing the role of neutrophils in peripheral regeneration 
 
Recent work has revealed novel ways in which immune cells, in particular cells of 
the innate immune system, participate in axonal regeneration. In the central 
nervous system, it has been found that neutrophils can promote optic nerve 
regeneration through the secretion of a protein called oncomodulin (Kurimoto et 
al., 2013). Neutrophils are among the first responders during an inflammatory 
response, and given their large numbers early during the course of nerve injury in 
the PNS, I wondered whether neutrophils may exert an influence on axonal 
regeneration in the periphery as well.  
 
To test this hypothesis, I depleted neutrophils in cohorts of mice in vivo using a 
highly specific antibody, Ly6G. Control cohorts received a corresponding isotype 
control (rat IgG2A). After neutrophil depletion was established, sciatic nerve 
crush injury was performed and restoration of sensory function over time was 
monitored through pinprick assay. As seen in Figure A2, no difference in 
functional recovery was seen between mice lacking neutrophils and mice 
receiving control antibody.   
 
Given results in the CNS showing a critical role for neutrophils (Kurimoto et al., 
2013), these results were surprising, but emphasize the differences between 
these two systems. Perhaps there is a quantitative or qualitative difference in the 
neutrophils in the CNS vs. the PNS. For example, it is possible that PNS 
neutrophils do not secrete oncomodulin, or that regeneration is so robust in the 
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PNS that any contribution from neutrophils is not necessary. Another possibility is 
that some other cell-type or signal acts to stimulate oncomodulin production. In 
any case, we found that neutrophils are dispensable for functional recovery of the 
PNS.  
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FIGURE A2: Neutrophil depletion does not alter functional recovery after 
nerve injury. Restoration of sensory recovery was measured in cohorts of C57 
mice with or without depletion of neutrophils. Mean +/- S.E.M is plotted; n = 8 
mice for each group.  
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The role of non-neuronal cells in the pre-conditioning effect 
 
 
As gleaned from the terminology, neuronal intrinsic growth has consistently been 
viewed as a neuronal-centric process; that is to say, one that is initiated and 
maintained by the neuron itself. Despite this, there is substantial evidence to 
suggest that this is not the complete picture. For example, as mentioned above, 
inducing an inflammatory response in the optic nerve can activate intrinsic growth 
in retinal ganglion cells. In the PNS, too, there are hints that robust neuronal 
intrinsic growth may in part dependent upon non-neuronal factors. For instance, 
culture of dissociated DRG sensory neurons will grow neurites in vitro, but the 
extent and rate of growth will never compare to that found in pre-conditioned 
neurons. This observation strongly suggests that "time" is not the only factor in 
activating regeneration-associated genes, but rather some in vivo component 
other than the neuron is participating.  
 
Given this, we wondered whether the presence or absence of non-neuronal cells 
could influence the pre-conditioning effect in vitro. To accomplish this, we either 
purified DRG neurons extensively, through multiple gradients (BSA and Percoll), 
or intentionally retained most of the non-neuronal cells by not purifying them at 
all. We then plated these cells on a permissive substrate for 5 days, re-plated 
them, and assessed neurite outgrowth. As seen in Figure A3, the presence of 
non-neuronal cells greatly enhances the in vitro pre-conditioning response. 
Unfortunately, substantial neurite outgrowth beyond a certain threshold makes 
quantification using automated software impossible.  
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Though preliminary in nature, and should be replicated more, these results add 
intriguing evidence to the case that the pre-conditioning effect may be in part 
driven by non-neuronal signals. The identity of these cell-types and signals 
remain completely unexplored, however, and future work should address this 
issue.  
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FIGURE A3: in vitro pre-conditioning is enhanced by the presence of non-
neuronal cells. Representative images of DRG neurons cultured in the presence 
(right) or absence (left) of non-neuronal cells within the DRG. ~1000 neuron were 
plated per well.   
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Assessing age-associated axonal regeneration in C. elegans  
 
 
At the outset of this thesis work several years ago, an age-associated decline in 
axonal regeneration had been observed histologically in a number of murine 
models, but whether this process was conserved in lower organisms had not 
been addressed. Axonal regeneration readily occurs in sensory systems of C. 
elegans, and as such, we wished to know whether aging impairs regeneration in 
a conserved manner. In collaboration with Christopher Gabel's group at Boston 
University, we performed specific laser ablation of individual sensory axons in 
cohorts of young (2 days) or old (1 week) C. elegans and tracked the regrowth of 
these axons over time using time-lapse video imaging. We observed a very 
robust effect of aging on both the time required to initiate axonal outgrowth as 
well as the total outgrowth over time (Figure A4), mirroring data we generated in 
aging mice (see Chapter 2).  
 
Because Wallerian degeneration does not occur in C. elegans, and in fact, axons 
simply regenerate around the cut axon, these data argue for a neuronal-intrinsic 
defect in C. elegans. Indeed, a recent publication confirmed that intrinsic 
mechanisms regulate the developmental decline in neuronal regeneration in 
worms (Zou et al., 2013). Thus, we conclude that age-related defects in C. 
elegans are likely the result of different mechanisms than in a mammalian 
system.  
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FIGURE A4: Axon regeneration is slower in aged C. elegans. Individual 
neurons of young (2-day) and aged (1-week) worms were ablated with lasers and 
subsequent axonal regeneration was measured using time-lapse photography. 
A) Total neurite outgrowth. B) Average time between laser ablation and initiation 
of neurite outgrowth. Plotted is mean +/- S.D.; n = 20-30. 
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FIGURE A4 (continued): Axon regeneration is slower in aged C. elegans.  
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Comparing transcriptional injury responses in the DRG and the distal 
stump 
 
In thinking about what defines regeneration-associated genes within DRG 
neurons, I have often noted the unusual overlap between genes known to play 
important roles in neuronal intrinsic growth, and those known to be important in 
regulating Schwann cell injury responses. For example, c-Jun is both a critical 
transcription factor in promoting axonal regeneration in neurons and a master 
regulator of Schwann cell de-differentiation. Among others, GAP-43 and ATF-3 
are also highly up-regulated in the distal stump after injury (see Chapter 2). 
Given this, I wondered more generally just how much of the transcriptional 
response is shared between the DRG and distal stump after nerve injury.  
 
To address this question, I first combined microarray data generated from 4 days 
after nerve injury from both the DRG and distal stump in young animals. I then 
compared the expression patterns before and after injury of each of these tissues 
on a Fold Change vs. Fold Change plot to get a rough estimate of how many 
genes activated after injury in one tissue were also activated in the other. Using 
2-fold change after injury as a standard cut-off, this analysis revealed that 
roughly 60% of the genes up or down regulated after nerve injury in the DRG are 
also activated in the same way in the distal stump (Figure A5). As seen along 
the X and Y axis, there are also a number of tissue-specific genes, as well as 
genes that exhibit the opposite mode of activation in one tissue versus the other. 
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Still, as shown by the large number of transcripts falling along the Y=X line, 
however, the expression of a surprising number of genes appear to be 
coordinated  in both tissues.  
 
There are at least two important points to be made from this analysis. The first is 
a cautionary tale when interpreting data from whole mouse knockout studies, or 
similar strategies that wish to address either Schwann cell responses or neuronal 
intrinsic growth without methods to confine the experiment to a single 
compartment. This is because it is a very likely that altering the function of a 
gene in both the neuronal and Schwann cell compartments would yield un-
interpretable data. The second point is a question: given this degree of 
transcriptional overlap, a degree that seems unlikely to be coincidental, what is 
the purpose of sharing injury programs? Certainly it is a question that begs closer 
examination in the future and suggests intriguing possibilities regarding axon and 
Schwann cell communication.   
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FIGURE A5: Analysis of injury-induced transcripts reveals broad 
similarities between programs utilized in the DRG and distal nerve stump. 
Fold-change vs. fold-change plot of expression data generated from naive and 
injured (4 days post nerve crush) DRG and distal nerve stump. Transcripts 
highlighted in blue represent fold change greater than 2 after injury in the DRG 
while those in red represent fold change less than 0. Dots are representative of 
averages of 3 independent biological replicates.  
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Enhancing neuronal intrinsic growth in aged animals in vivo 
 
 
In Chapter 2, we concluded that neuronal intrinsic growth was unlikely to be a 
major factor influencing the aging regeneration phenotype. In addition to the 
experiments described in Chapter 2, we also performed a preliminary 
experiment intended to push the question of intrinsic growth to a more extreme 
position. In this case, we not only wished to know whether intrinsic growth was 
failing in aged animals, but whether boosting intrinsic growth could rescue the 
aging phenotype regardless of its source. To accomplish this, we took advantage 
of Hsp27 over-expressing mice, which show accelerated axonal growth after 
nerve injury (Ma et al., 2011). We performed sciatic nerve crush injury on a small 
cohort of ~24 month old Hsp27 transgenic mice and compared the rate of 
restoration of sensory functional recovery over time to previously generated data 
from young and aged animals. Interestingly, we found that functional recovery of 
aged Hsp27 animals compared extremely well to that of non-transgenic aged 
animals (Figure A6). Although these data were not included in the manuscript 
because of low n number and lack of adequate control animals, they suggest that 
boosting neuronal intrinsic growth cannot accelerate regeneration in aged 
animals. These results are consistent with a dominant extrinsic effect of aging on 
regeneration as proposed in Chapter 2.   
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FIGURE A6: Enhancing intrinsic growth does not rescue the aging 
phenotype. Rate of restoration of sensory function over time in 2 year old Hsp-
27 transgenic mice. Plotted is mean +/- S.E.M., n=4. Red and Blue represent 
previously generated data (see Chapter 2) for sake of comparison.  
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Assessing age-dependent effects of Schwann cells in promoting neurite 
outgrowth in vitro 
 
Among the possible ways that aged Schwann cells might influence the course of 
axonal regeneration is through reduced secretion of growth-promoting factors or 
by functionally providing a less adequate substrate for axonal growth. To test 
whether aging Schwann cells might directly hinder neurite outgrowth, or whether 
young Schwann cells might enhance growth, we co-cultured young and aged 
Schwann cells with young and aged neurons and assessed neurite outgrowth 
after 17 hours on a permissive substrate. While there appears to be an 
interesting trend, overall the effect of Schwann cells on growth did not have a 
statistically significant effect (Figure A7). We did not try Schwann cell 
conditioned media, but this would have been worthwhile.   
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FIGURE A7: Schwann cell and neuronal co-culture experiments. 
Old or young Schwann cells were cultured with old or young DRG neurons and 
subsequent neurite outgrowth was measured after 17 hours. O=old Y=young; 
YN:OS = young neurons, old Schwann cells, ON:YS= old neurons, young 
Schwann cells. Plotted is mean +/- S.E.M, n = 4 wells per condition. NS = not 
significant by one-way ANOVA.  
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Methods 
Microarray profiling and analysis. 
Microarray profiling was generally performed according to methods in Chapter 2. 
In brief, commons pools of RNA were derived from L5 and L6 DRGs from cohorts 
of C57BL6/J mice, amplified using standard Ambion kits, and the resulting cDNA 
hybridized to Affymetrix 430 whole genome mouse arrays. Analysis was 
conducted in Multiplot software, also described in Chapter 2.  
Neutrophil depletion. 
Neutrophils were depleted according to methods found in (Daley et al., 2008). 
Briefly, neutrophils were depleted by I.P. administration of 0.5mg Ly6G antibody 
(1A8 hybridoma from BioXcell) 3 days prior to sciatic nerve crush injury, and 
every 2 days after until full restoration of sensory recovery in the mice.  
Schwann cell culture. 
1 cm long segments of the sciatic nerve were harvested from C57 mice and 
allowed to incubate in DMEM for 2 weeks. This allows Schwann cells to 
proliferate and the nerve to degenerate. After incubation, nerves were placed in a 
mixture of collagenase and dispase at 37 degrees Celsius (as with DRGs) for 2 
hours. Nerves were then directly titurated using a glass pasteur pipette in 2ml of 
DMEM. The resulting cell suspension was filtered and results in approximately 
80-90% Schwann cells.   
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Mouse behavior. 
Restoration of sensory recovery in mice was accomplished through the pinprick 
assay as described in methods in Chapter 2.  
DRG and non-neuronal purification and culture.  
Dissociated DRG neurons were obtained and cultured using methods described 
in Chapter 2. Non-neuronal cells were obtained by dissociating the entire DRG 
tissue as previously described, but without the use of neuronal cell purifying 
gradients (Percoll and BSA).  
Femtosecond laser ablation and time-lapse imaging in C. elegans.  
Laser ablation and imaging were performed according to previously described 
methods (Chung et al., 2013).  
Transgenic mice. 
Hsp27 transgenic mice were generated according to methods described 
previously (Ma et al., 2011).  
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SUPPLEMENTAL TABLES 
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IlluminaProbeI
D 
Gene 
Symbol Fold Change (Young injured v.s aged injured) 
ILMN_2878542 Myl1 3.13 
ILMN_2738825 Acta1 2.65 
ILMN_2794342 Pmp2 2.45 
ILMN_2997494 Lox 2.28 
ILMN_1248316 Ptgds 2.24 
ILMN_2666864 Atp2a1 2.19 
ILMN_2717765 Ednrb 2.10 
ILMN_2882658 Tnnc2 2.09 
ILMN_2648669 Gpnmb 0.33 
ILMN_1238886 Ccl8 0.33 
ILMN_2712075 Lcn2 0.38 
ILMN_2754364 Ltf 0.47 
ILMN_2846865 Actb 0.49 
ILMN_1228832 Ngp 0.50 
 
Table S1: Differentially expressed DRG genes between young and aged 
after injury.  
Red: genes over-expressed in young greater than 2-Fold. Blue: genes under-
expressed in young greater than 2-Fold (less than 0.5).  
  
 108 
IlluminaProbeID GeneSymbol Fold Change (young naive vs. aged naive) 
ILMN_2875730 MUP1 5.79 
ILMN_2737163 SQLE 4.76 
ILMN_2688075 CYP51 4.55 
ILMN_2600348 SQLE 4.48 
ILMN_1225730 FDPS 4.31 
ILMN_3065459 MUP2 4.17 
ILMN_1239557 UGT8 3.12 
ILMN_2614752 ELOVL6 3.09 
ILMN_1229529 HSD17B7 3.08 
ILMN_2443330 TTR 2.95 
ILMN_2676379 PON1 2.90 
ILMN_2823778 SC4MOL 2.84 
ILMN_2654952 HMGCS1 2.80 
ILMN_1247358 EMID2 2.80 
ILMN_1253601 AACS 2.79 
ILMN_1253806 COL1A2 2.65 
ILMN_2543108 WDT3-PENDING 2.63 
ILMN_1229547 SPON2 2.60 
ILMN_1258629 COL3A1 2.60 
ILMN_2794342 PMP2 2.59 
ILMN_2594525 NSDHL 2.53 
ILMN_2909105 2310047D13RIK 2.50 
ILMN_2683958 COL3A1 2.45 
ILMN_2607377 ITM2A 2.45 
ILMN_2731446 SERPIND1 2.31 
ILMN_1245272 INSIG1 2.28 
ILMN_1216661 COL6A2 2.27 
ILMN_1225835 MFAP5 2.27 
ILMN_1215136 SCN3B 2.26 
ILMN_2592953 SGNE1 2.26 
ILMN_2768087 COL6A1 2.26 
ILMN_1259388 COL6A1 2.25 
ILMN_2734181 ACAS2 2.24 
ILMN_2997494 LOX 2.23 
ILMN_2594521 NSDHL 2.23 
ILMN_2939303 PCYT2 2.16 
ILMN_2687872 COL1A1 2.16 
ILMN_1377923 ACTB 2.13 
ILMN_2645275 MVD 2.11 
ILMN_2814357 GM239 2.10 
ILMN_1240445 STARD4 2.09 
ILMN_2747031 DHCR24 2.07 
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ILMN_2874422 ANGPTL1 2.05 
ILMN_2724226 4833439L19RIK 2.05 
ILMN_2866856 H2-DMA 2.04 
ILMN_2606693 INSIG1 2.03 
ILMN_1246821 E130203B14RIK 2.02 
ILMN_1250507 ELOVL4 2.01 
ILMN_2604224 SEMA5A 1.96 
ILMN_2766930 FAAH 1.96 
ILMN_2877507 PIGQ 1.94 
ILMN_2946970 THEM5 1.93 
ILMN_2781458 TLCD1 1.92 
ILMN_2794645 CYR61 1.92 
ILMN_2762397 FBXO25 1.91 
ILMN_2597485 PCYT2 1.89 
ILMN_2619846 SLC25A1 1.88 
ILMN_1245328 BB146404 1.88 
ILMN_2672708 LRP11 1.86 
ILMN_2804166 IGSF9 1.85 
ILMN_2604226 SEMA5A 1.85 
ILMN_2606579 GPSN2 1.85 
ILMN_2675697 KDELR3 1.84 
ILMN_1222111 COL15A1 1.84 
ILMN_2894125 FOXI2 1.84 
ILMN_2752940 DHCR24 1.83 
ILMN_2953807 LOC620807 1.83 
ILMN_2633350 MFAP4 1.82 
ILMN_2911307 GM347 1.81 
ILMN_2687165 CHST2 1.81 
ILMN_2620106 DHCR24 1.80 
ILMN_1242170 ADRA2A 1.80 
ILMN_1231274 CKLFSF5 1.80 
ILMN_2667829 PRKCQ 1.79 
ILMN_2734755 COL4A5 1.79 
ILMN_2671601 SELK 1.78 
ILMN_2974720 IGF2BP2 1.78 
ILMN_1217235 9130005N14RIK 1.78 
ILMN_2634169 CLDN19 1.78 
ILMN_2674720 TEBP 1.77 
ILMN_2611755 SERPINB6B 1.77 
ILMN_2630605 FSCN1 1.77 
ILMN_2643495 FEZ1 1.77 
ILMN_1232182 CATNBIP1 1.76 
ILMN_1253008 ACAT2 1.76 
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ILMN_3138743 ACSL3 1.76 
ILMN_2444505 SCL0003251.1_21 1.76 
ILMN_2736867 LYZ 1.75 
ILMN_2492264 WISP1 1.75 
ILMN_2738054 PLEKHG2 1.74 
ILMN_1237021 MAG 1.74 
ILMN_1255473 0610040B21RIK 1.74 
ILMN_2657980 FAAH 1.74 
ILMN_2729103 ADAMTS2 1.73 
ILMN_1242246 SCAMP5 1.73 
ILMN_1226356 AI427515 1.72 
ILMN_1248837 TBXA2R 1.71 
ILMN_1223598 SREBP2 1.71 
ILMN_2746783 FA2H 1.71 
ILMN_2680262 POLR2G 1.71 
ILMN_1232261 CATNAL1 1.70 
ILMN_1225764 1700018O18RIK 1.70 
ILMN_1223594 LOC217066 1.70 
ILMN_2966162 TMEM56 1.70 
ILMN_2993962 BC099439 1.69 
ILMN_2909238 SPNB1 1.69 
ILMN_2710784 GPSN2 1.69 
ILMN_2664884 TSPAN17 1.69 
ILMN_2829636 DNAJB9 1.68 
ILMN_2679386 GSN 1.68 
ILMN_2725402 NSDHL 1.68 
ILMN_2756665 CBR2 1.67 
ILMN_2729289 MATN4 1.67 
ILMN_2669062 PI16 1.67 
ILMN_3143506 ELOVL1 1.67 
ILMN_1221919 CLCN3 1.67 
ILMN_2718204 SCGF 1.67 
ILMN_2631518 SERF1 1.66 
ILMN_2514377 CXADR 1.66 
ILMN_1236175 TUBB4 1.65 
ILMN_2639239 SERPINF1 1.65 
ILMN_2694038 PCYT2 1.65 
ILMN_2713673 2310016A09RIK 1.65 
ILMN_2919263 SLC25A1 1.65 
ILMN_2947948 ANKRD38 1.65 
ILMN_1255871 LOXL1 1.65 
ILMN_1258028 GAL3ST1 1.64 
ILMN_1257333 2310022B05RIK 1.64 
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ILMN_2907964 CRIM2 1.64 
ILMN_2728830 TAF13 1.64 
ILMN_2981542 MFAP2 1.64 
ILMN_1224780 ELOVL1 1.63 
ILMN_2976601 TFG 1.63 
ILMN_2675090 DUSP15 1.63 
ILMN_2593225 PRX 1.63 
ILMN_2879876 TBC1D23 1.63 
ILMN_2674221 TBC1D7 1.63 
ILMN_2817329 MPZ 1.63 
ILMN_2748402 COL5A1 1.62 
ILMN_1214602 SFRP2 1.62 
ILMN_2717228 D930005D10RIK 1.62 
ILMN_2804636 RNUXA 1.62 
ILMN_1246655 PLEKHG2 1.62 
ILMN_1222036 MPRA 1.61 
ILMN_2701778 ITGA11 1.61 
ILMN_1216662 KIF5C 1.61 
ILMN_1240728 D430044G18RIK 1.61 
ILMN_2634338 1110002B05RIK 1.61 
ILMN_2697304 ELN 1.61 
ILMN_2713071 FADS2 1.61 
ILMN_1256702 S100A10 1.61 
ILMN_2827617 SORCS1 1.61 
ILMN_3162239 PRR7 1.60 
ILMN_2757268 TBC1D7 1.60 
ILMN_2956095 RASSF4 1.60 
ILMN_1216987 ABCA2 1.60 
ILMN_1234879 SFRP4 1.60 
ILMN_3143404 MUP2 1.60 
ILMN_2697499 NOPE 1.60 
ILMN_2641152 NPHP4 1.59 
ILMN_2882059 RPL27A 1.59 
ILMN_1225039 SC5D 1.58 
ILMN_2932705 MYOC 1.58 
ILMN_3078052 AK129302 1.58 
ILMN_2671755 CEECAM1 1.58 
ILMN_2849285 KRT10 1.58 
ILMN_2598103 EMP2 1.57 
ILMN_3160659 DOK2 1.57 
ILMN_3163350 CLDN19 1.57 
ILMN_2690014 SYT4 1.57 
ILMN_1232025 2410015B03RIK 1.57 
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ILMN_1245780 C130076O07RIK 1.56 
ILMN_2649456 E130201N16RIK 1.56 
ILMN_2718189 CHN2 1.56 
ILMN_2646985 ATF5 1.56 
ILMN_1256121 ZFP282 1.56 
ILMN_2640995 SPIRE2 1.56 
ILMN_2654554 FGL2 1.56 
ILMN_3048492 ABCC5 1.55 
ILMN_2633897 PDE6D 1.55 
ILMN_2758070 RTN1 1.55 
ILMN_2694245 SRP14 1.55 
ILMN_3132186 PCYT1B 1.55 
ILMN_2899318 RDH11 1.55 
ILMN_2731550 BRP17 1.55 
ILMN_1232458 C1QTNF2 1.54 
ILMN_2722864 NCAM1 1.54 
ILMN_1238603 PCOLCE2 1.54 
ILMN_1230145 ACVR2B 1.54 
ILMN_2859619 OGN 1.54 
ILMN_2760485 MAPK8IP1 1.54 
ILMN_1224029 MAL 1.54 
ILMN_3029489 GM129 1.54 
ILMN_2656871 1810014L12RIK 1.54 
ILMN_2644719 HMGN3 1.54 
ILMN_2944610 ISLR2 1.54 
ILMN_2493175 TST 1.54 
ILMN_1225029 OACT1 1.54 
ILMN_1225494 AU040950 1.54 
ILMN_2663249 SLAMF9 1.54 
ILMN_1219583 CAPN2 1.54 
ILMN_1259737 DCUN1D4 1.54 
ILMN_1229553 IGSF3 1.53 
ILMN_2613869 CLPX 1.53 
ILMN_2874554 ALDH4A1 1.53 
ILMN_2630182 SYP 1.53 
ILMN_2826916 PTPRE 1.53 
ILMN_1216021 TTYH1 1.53 
ILMN_2972478 NLGN2 1.53 
ILMN_1213056 FEZ1 1.53 
ILMN_2728985 FBLN1 1.53 
ILMN_2706677 D330045A20RIK 1.53 
ILMN_3009501 KCNK1 1.53 
ILMN_1231492 ITGA6 1.53 
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ILMN_2737840 TBXA2R 1.52 
ILMN_2713538 BMP1 1.52 
ILMN_2650447 COL23A1 1.52 
ILMN_1222602 2410014A08RIK 1.52 
ILMN_1226114 MYH10 1.52 
ILMN_1216035 SIAT8E 1.52 
ILMN_2600565 MAGED2 1.52 
ILMN_1232099 TM4SF8 1.52 
ILMN_2788121 DYNLL1 1.52 
ILMN_2616956 4933434E20RIK 1.52 
ILMN_2596499 BC058638 1.52 
ILMN_2790373 SNN 1.52 
ILMN_3059326 SPARC 1.52 
ILMN_2607529 NR2F1 1.51 
ILMN_1377919 TUBB2B 1.51 
ILMN_1244977 H2-DMB1 1.51 
ILMN_2433547 TRP53BP1 1.51 
ILMN_1248714 DAF1 1.51 
ILMN_2702266 CRYGS 1.51 
ILMN_3154269 PRX 1.51 
ILMN_2595597 ANLN 1.51 
ILMN_1219915 DGAT2 1.51 
ILMN_2893564 1190007F08RIK 1.51 
ILMN_2883795 DCUN1D4 1.50 
ILMN_2515784 TM4SF6 1.50 
ILMN_1230411 KPNB1 1.50 
ILMN_2594139 6330403K07RIK 1.50 
ILMN_1223307 4933424M23RIK 1.50 
ILMN_2596230 2410014A08RIK 1.50 
ILMN_1248788 0610005K03RIK 1.50 
ILMN_2916705 TUBA1A 1.50 
ILMN_2610013 SHH 0.14 
ILMN_1260428 MYL2 0.14 
ILMN_2954987 MB 0.16 
ILMN_2977331 MYLPF 0.16 
ILMN_2882658 TNNC2 0.18 
ILMN_2416670 TTN 0.19 
ILMN_3128792 TTN 0.20 
ILMN_2629581 COX6A2 0.20 
ILMN_2608804 CKM 0.20 
ILMN_2481133 TNNI2 0.21 
ILMN_2666864 ATP2A1 0.21 
ILMN_2933357 TCAP 0.21 
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ILMN_2789650 CSRP3 0.23 
ILMN_1238886 CCL8 0.24 
ILMN_2738825 ACTA1 0.25 
ILMN_2648669 GPNMB 0.26 
ILMN_2733708 RBP7 0.26 
ILMN_1235070 NRAP 0.27 
ILMN_2676012 MYBPC2 0.30 
ILMN_2460136 TNNT1 0.30 
ILMN_2691780 MYL3 0.31 
ILMN_2503052 TNNC1 0.31 
ILMN_2613038 1110033I14RIK 0.31 
ILMN_2482209 TPM2 0.32 
ILMN_2817864 CKMT2 0.32 
ILMN_2747543 ACTN3 0.33 
ILMN_2698052 CKMT2 0.33 
ILMN_2797061 ACTN2 0.33 
ILMN_2469018 TNNT3 0.33 
ILMN_2757569 ENO3 0.34 
ILMN_2649810 RPL3L 0.35 
ILMN_2759365 ANGPTL4 0.36 
ILMN_1216042 APOE 0.36 
ILMN_2742068 CSRP3 0.37 
ILMN_1227675 SLC4A1 0.38 
ILMN_2992709 TREM2 0.38 
ILMN_2749037 NDG2 0.38 
ILMN_1218223 PVALB 0.38 
ILMN_3064283 PDE4DIP 0.38 
ILMN_2622671 ACSL1 0.41 
ILMN_1222679 CIDEC 0.41 
ILMN_2730425 RYR1 0.42 
ILMN_3091003 MS4A7 0.43 
ILMN_2887630 FABP3 0.43 
ILMN_3008110 ACTN3 0.43 
ILMN_1235372 HBB-B1 0.43 
ILMN_2614655 GPNMB 0.43 
ILMN_1229990 AGXT2L1 0.43 
ILMN_2665133 TIMP4 0.44 
ILMN_2629112 CRG-L1 0.44 
ILMN_2805339 HSPB6 0.44 
ILMN_2642417 MEST 0.45 
ILMN_2918875 SLN 0.45 
ILMN_2640097 AOX3 0.45 
ILMN_2485323 TRF 0.45 
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ILMN_2675874 ALAS2 0.46 
ILMN_1214998 HSD11B1 0.47 
ILMN_2440530 VAT1 0.47 
ILMN_2860479 ARPC1B 0.47 
ILMN_2965903 HDC 0.47 
ILMN_2708303 ACTN3 0.47 
ILMN_2689785 CD68 0.48 
ILMN_1245079 ADSSL1 0.49 
ILMN_2765759 ASB2 0.49 
ILMN_2958099 ADSSL1 0.49 
ILMN_1235230 PDLIM3 0.49 
ILMN_1237871 LOC229665 0.50 
ILMN_1241350 VSIG4 0.50 
ILMN_2873444 FBXO32 0.50 
ILMN_2741117 ANKRD23 0.50 
ILMN_1234662 MB 0.50 
ILMN_2774160 HSD11B1 0.50 
ILMN_2488846 TMOD4 0.50 
ILMN_2878542 MYL1 0.50 
ILMN_3115917 HSD11B1 0.50 
ILMN_1257299 G0S2 0.51 
ILMN_1246800 SERPINA3N 0.51 
ILMN_2727520 COX8B 0.51 
ILMN_2599130 ALDOA 0.51 
ILMN_2694179 CCL6 0.51 
ILMN_1246139 CLDN11 0.52 
ILMN_2473620 RSN 0.52 
ILMN_2756046 GPR43 0.52 
ILMN_2661366 BC018222 0.52 
ILMN_2588249 S3-12 0.52 
ILMN_1259206 HRC 0.52 
ILMN_2873822 AEBP1 0.53 
ILMN_2897617 RPS10 0.53 
ILMN_2588815 PGAM2 0.53 
ILMN_2864309 LOC100034251 0.53 
ILMN_2617468 1810008K03RIK 0.53 
ILMN_2733073 RYR1 0.54 
ILMN_2665387 CORO1C 0.54 
ILMN_2835683 H2-GS17 0.54 
ILMN_2706269 HSPB1 0.54 
ILMN_2760019 CXCL13 0.54 
ILMN_2690122 SLC27A1 0.54 
ILMN_2836982 DES 0.54 
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ILMN_2960114 CYP27A1 0.54 
ILMN_2760979 TGFBR2 0.55 
ILMN_2771219 1110001A05RIK 0.55 
ILMN_2642681 ATF4 0.55 
ILMN_2628892 PFKM 0.55 
ILMN_1259322 PDK4 0.55 
ILMN_1225204 2510004L01RIK 0.55 
ILMN_2987339 MYBBP1A 0.55 
ILMN_3136283 LDB3 0.55 
ILMN_2661820 AGXT2L1 0.55 
ILMN_3052430 CD63 0.55 
ILMN_2815138 MYOM1 0.56 
ILMN_3151722 NET1 0.56 
ILMN_2715546 GPX3 0.56 
ILMN_3049559 C4B 0.56 
ILMN_2444217 TTID 0.56 
ILMN_3154640 AFF1 0.56 
ILMN_3137899 OTOP1 0.56 
ILMN_2752994 FBXO32 0.56 
ILMN_2968211 LGALS4 0.57 
ILMN_2689880 GSTT2 0.57 
ILMN_2688416 D11ERTD736E 0.57 
ILMN_2619200 ERAF 0.57 
ILMN_1250904 RTN2 0.57 
ILMN_1225376 SMOC1 0.57 
ILMN_1217969 GPIHBP1 0.57 
ILMN_3153940 CMYA4 0.57 
ILMN_2740151 CHPT1 0.57 
ILMN_1216322 HMGCS2 0.57 
ILMN_2604494 PODXL 0.57 
ILMN_2712075 LCN2 0.57 
ILMN_2692644 BC054059 0.57 
ILMN_1214880 DMN 0.57 
ILMN_2727503 IGFBP3 0.58 
ILMN_2878071 LYZ 0.58 
ILMN_3137570 PDLIM5 0.58 
ILMN_2654896 RPL37A 0.58 
ILMN_2944601 4933439C20RIK 0.58 
ILMN_1244188 H6PD 0.58 
ILMN_2863390 FCER1A 0.58 
ILMN_2666990 EEF1A2 0.58 
ILMN_3100812 GPX4 0.58 
ILMN_2798129 C6 0.58 
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ILMN_2669714 PLTP 0.58 
ILMN_1252076 LYZS 0.58 
ILMN_2907370 OPTN 0.58 
ILMN_3148662 SFRS5 0.59 
ILMN_1240898 RPS21 0.59 
ILMN_2671517 RPS15 0.59 
ILMN_3126986 RPS24 0.59 
ILMN_2955104 NACA 0.59 
ILMN_1257631 APOBEC1 0.59 
ILMN_1240746 MCPT4 0.59 
ILMN_2843355 PCBP2 0.59 
ILMN_2802979 SHH 0.59 
ILMN_2519313 TMOD4 0.59 
ILMN_2621921 CLCN7 0.59 
ILMN_1250000 1500003O03RIK 0.60 
ILMN_2769918 TIMP1 0.60 
ILMN_2644350 THY1 0.60 
ILMN_1225261 UCHL1 0.60 
ILMN_3112873 TXNIP 0.60 
ILMN_2918499 ABCB1B 0.60 
ILMN_2862567 FNDC3B 0.60 
ILMN_2732401 C130068O12RIK 0.60 
ILMN_2857666 COL24A1 0.60 
ILMN_2980663 AQP1 0.60 
ILMN_1254523 GSTO1 0.60 
ILMN_2718589 FCNA 0.60 
ILMN_3083163 CP 0.60 
ILMN_3125606 D12ERTD647E 0.60 
ILMN_2687745 PNPLA2 0.61 
ILMN_2869225 RPL19 0.61 
ILMN_2438793 TMOD4 0.61 
ILMN_2846904 MEST 0.61 
ILMN_2658687 LTC4S 0.61 
ILMN_2674575 MMD 0.61 
ILMN_2672190 IDB1 0.61 
ILMN_2655260 PTP4A3 0.61 
ILMN_1227972 RPS16 0.61 
ILMN_1221060 PPARG 0.61 
ILMN_2705886 SCP2 0.61 
ILMN_3121255 VEGFA 0.61 
ILMN_2971559 EEF1A2 0.61 
ILMN_2631161 FCRL3 0.61 
ILMN_2885990 PDLIM3 0.61 
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ILMN_2463180 TNC 0.61 
ILMN_2663832 FAU 0.62 
ILMN_2705628 CLECSF8 0.62 
ILMN_2877029 CYTL1 0.62 
ILMN_1241214 MYH4 0.62 
ILMN_3125966 KCNJ15 0.62 
ILMN_2714638 MERTK 0.62 
ILMN_2652500 LRG1 0.62 
ILMN_1222246 ADFP 0.62 
ILMN_1247811 ASS1 0.62 
ILMN_2745555 MRPS21 0.62 
ILMN_2771034 MFGE8 0.62 
ILMN_3161554 VPS11 0.62 
ILMN_2615250 MYOZ1 0.62 
ILMN_1228657 FCGR2B 0.62 
ILMN_3103896 TIMP1 0.62 
ILMN_2742152 GADD45A 0.62 
ILMN_2947568 GADD45A 0.63 
ILMN_1223317 LGALS3 0.63 
ILMN_2957161 SMYD2 0.63 
ILMN_2637233 PRDX5 0.63 
ILMN_2840985 ST6GALNAC5 0.63 
ILMN_2694955 IGFBP4 0.63 
ILMN_2614531 MCAM 0.63 
ILMN_2613399 SCYE1 0.63 
ILMN_2746895 GPR120 0.63 
ILMN_2943165 AQP7 0.63 
ILMN_2610771 NET1 0.63 
ILMN_2630946 APRT 0.63 
ILMN_2463181 TNC 0.64 
ILMN_2770066 CYP4F18 0.64 
ILMN_2968515 XPA 0.64 
ILMN_1255047 C80638 0.64 
ILMN_2721357 LHFPL2 0.64 
ILMN_2626235 LGALS4 0.64 
ILMN_2947292 MAP3K6 0.64 
ILMN_2737302 CXCL12 0.64 
ILMN_2624018 EEF1D 0.64 
ILMN_2653215 NAGK 0.64 
ILMN_1212636 STRAP 0.64 
ILMN_1241390 4933408F15 0.64 
ILMN_2874228 RPL12 0.64 
ILMN_2872552 LOC622404 0.64 
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ILMN_1254987 MBNL2 0.64 
ILMN_1231275 LOC381480 0.64 
ILMN_2796798 5730469M10RIK 0.65 
ILMN_1250213 SH3GLB1 0.65 
ILMN_2596259 2410001C21RIK 0.65 
ILMN_2971142 AMPD1 0.65 
ILMN_2629663 E430002D04RIK 0.65 
ILMN_2761109 CLIC4 0.65 
ILMN_2687586 CXCL16 0.65 
ILMN_1255556 PINK1 0.65 
ILMN_2679937 PBXIP1 0.65 
ILMN_2959863 NTN4 0.65 
ILMN_2693403 ELA1 0.65 
ILMN_1256257 G1P2 0.65 
ILMN_1258526 LGALS3BP 0.65 
ILMN_2740152 CHPT1 0.65 
ILMN_1241695 MS4A6D 0.65 
ILMN_2910934 CD52 0.65 
ILMN_2668509 HP 0.65 
ILMN_2451022 VIM 0.65 
ILMN_2606295 GCH1 0.65 
ILMN_1225727 CMA1 0.65 
ILMN_2589785 CNN3 0.65 
ILMN_2692615 TGM2 0.66 
ILMN_2937735 IRAK2 0.66 
ILMN_1235493 FXYD5 0.66 
ILMN_3066763 ARL4 0.66 
ILMN_2879506 2310037I24RIK 0.66 
ILMN_3127391 NPR3 0.66 
ILMN_3158250 CXCL12 0.66 
ILMN_2753809 MMP3 0.66 
ILMN_2712120 S100A6 0.66 
ILMN_2754698 CD84 0.66 
ILMN_1225658 UBL3 0.66 
ILMN_3162925 LOC620078 0.66 
ILMN_2705881 SCP2 0.66 
ILMN_2653617 CD63 0.66 
ILMN_2422333 TRAP1 0.66 
ILMN_2952098 A930034L06RIK 0.66 
ILMN_2721337 G6PDX 0.66 
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Table S2: Differentially expressed sciatic nerve genes between young and 
aged under naive conditions. Red: genes over-expressed in young greater 
than 1.5-Fold; Blue: genes over-expressed in aged greater than 1.5-Fold (less 
than 0.66).  
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IlluminaProbeI
D GeneSymbol 
Fold Change (young injured vs. aged 
injured) 
ILMN_1253178 ALDH3A1 4.73 
ILMN_2875730 MUP1 3.73 
ILMN_2621448 ADH7 3.24 
ILMN_1244618 DLK1 2.69 
ILMN_3065459 MUP2 2.64 
ILMN_1226472 RETNLA 2.44 
ILMN_2638114 PTN 2.44 
ILMN_1236788 IGFBP2 2.31 
ILMN_2929896 PBK 2.10 
ILMN_2607377 ITM2A 2.06 
ILMN_1248788 0610005K03RIK 2.02 
ILMN_3127335 SYTL2 2.02 
ILMN_1216661 COL6A2 1.92 
ILMN_2930897 IGFBP2 1.89 
ILMN_2841593 FGFBP3 1.89 
ILMN_3160486 2310037P21RIK 1.88 
ILMN_2676379 PON1 1.84 
ILMN_2681241 BIRC5 1.81 
ILMN_3143404 MUP2 1.77 
ILMN_2653207 TEAD2 1.75 
ILMN_2998813 SEMA4F 1.73 
ILMN_1247933 LYZ 1.71 
ILMN_2513826 TNFRSF11B 1.70 
ILMN_2734097 BTC 1.70 
ILMN_2602139 CCL21A 1.69 
ILMN_2836654 HIST1H2AO 1.67 
ILMN_2970623 CENPP 1.67 
ILMN_2612206 CDC20 1.67 
ILMN_1218967 KIF2C 1.66 
ILMN_2646296 D4BWG0951E 1.66 
ILMN_2663328 2600001J17RIK 1.65 
ILMN_1240125 GNB4 1.65 
ILMN_2756421 LRRC15 1.65 
ILMN_2977404 TMOD1 1.64 
ILMN_1259610 6030411F23RIK 1.64 
ILMN_2757125 PRC1 1.63 
ILMN_2847144 HIST1H2AK 1.63 
ILMN_1212907 
D430039N05RI
K 1.62 
ILMN_2830661 TOP2A 1.62 
ILMN_1255053 PLK1 1.61 
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ILMN_1234990 GAP43 1.61 
ILMN_2599385 EPHA5 1.60 
ILMN_2953807 LOC620807 1.60 
ILMN_2867899 CDC20 1.59 
ILMN_2603699 BIRC5 1.59 
ILMN_2729289 MATN4 1.59 
ILMN_2595597 ANLN 1.59 
ILMN_1227352 ADAMTS19 1.59 
ILMN_2745930 TAGLN3 1.58 
ILMN_2593631 3000004C01RIK 1.58 
ILMN_2753497 CCNB1 1.58 
ILMN_2947568 GADD45A 1.58 
ILMN_3123864 KCNH2 1.57 
ILMN_2901180 SPC25 1.57 
ILMN_2600744 RGS16 1.57 
ILMN_2657844 CDC2A 1.57 
ILMN_1245789 CCNE2 1.56 
ILMN_1259388 COL6A1 1.56 
ILMN_2669172 4930547N16RIK 1.56 
ILMN_3132588 
D930038M13RI
K 1.55 
ILMN_2643049 CHST8 1.55 
ILMN_2785104 SFRS7 1.55 
ILMN_1223045 2810417H13RIK 1.55 
ILMN_1247358 EMID2 1.55 
ILMN_3161959 
E130016E03RI
K 1.54 
ILMN_2795040 HIST1H2AD 1.54 
ILMN_2649291 LIP1 1.54 
ILMN_1255960 SPC25 1.54 
ILMN_2878501 NEDD4L 1.54 
ILMN_2867901 CDC20 1.54 
ILMN_1237399 RIT2 1.54 
ILMN_2778872 MAD2L1 1.53 
ILMN_2797642 NCAPH 1.52 
ILMN_2604226 SEMA5A 1.52 
ILMN_2656854 MYO6 1.52 
ILMN_2642743 FGF5 1.52 
ILMN_2762326 KIF22 1.52 
ILMN_2900557 KIF15 1.52 
ILMN_2588362 CDCA8 1.51 
ILMN_2632712 BIRC5 1.51 
ILMN_1220039 KIF4 1.50 
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ILMN_2875585 PLF2 0.23 
ILMN_2996648 MRPPLF3 0.28 
ILMN_2772632 SAA3 0.37 
ILMN_2991799 CPA3 0.37 
ILMN_2710905 S100A8 0.38 
ILMN_1240746 MCPT4 0.40 
ILMN_2760800 CXCL14 0.40 
ILMN_2659426 CXCL14 0.42 
ILMN_2863390 FCER1A 0.42 
ILMN_1241350 VSIG4 0.43 
ILMN_2997068 CMA1 0.43 
ILMN_2642800 SOSTDC1 0.43 
ILMN_2803674 S100A9 0.44 
ILMN_2698449 DTR 0.44 
ILMN_3158250 CXCL12 0.44 
ILMN_2760019 CXCL13 0.45 
ILMN_1242457 FPR-RS2 0.46 
ILMN_2737302 CXCL12 0.46 
ILMN_2794342 PMP2 0.46 
ILMN_2817329 MPZ 0.46 
ILMN_1223257 CCL4 0.46 
ILMN_2965903 HDC 0.47 
ILMN_3154269 PRX 0.47 
ILMN_1246139 CLDN11 0.47 
ILMN_2609590 CPA3 0.49 
ILMN_2595664 DHH 0.49 
ILMN_2712075 LCN2 0.50 
ILMN_2656748 DFY 0.50 
ILMN_2668510 HP 0.50 
ILMN_2668509 HP 0.50 
ILMN_1225727 CMA1 0.51 
ILMN_2756046 GPR43 0.52 
ILMN_1246800 SERPINA3N 0.52 
ILMN_2593225 PRX 0.53 
ILMN_2753809 MMP3 0.53 
ILMN_3154691 SIRPB1 0.53 
ILMN_2959291 UPP1 0.54 
ILMN_2860804 TFRC 0.54 
ILMN_2620406 NPTX2 0.54 
ILMN_3161036 MCPT6 0.55 
ILMN_3157658 CD209B 0.55 
ILMN_2944824 HP 0.55 
ILMN_2619848 TFRC 0.55 
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ILMN_2899041 MMP3 0.56 
ILMN_2903169 GM484 0.56 
ILMN_2995688 EG433016 0.57 
ILMN_1214483 CRABP2 0.57 
ILMN_2738082 ACDC 0.57 
ILMN_2658908 CXCL12 0.57 
ILMN_2661299 PMP22 0.57 
ILMN_1249941 GDF10 0.58 
ILMN_2622671 ACSL1 0.58 
ILMN_2704576 MMP3 0.58 
ILMN_1228535 PMP22 0.58 
ILMN_1220697 NOTCH4 0.59 
ILMN_2712986 CHI3L3 0.59 
ILMN_2503052 TNNC1 0.59 
ILMN_1224029 MAL 0.59 
ILMN_2602352 MS4A6D 0.59 
ILMN_1212619 4933428A15RIK 0.59 
ILMN_2777498 IL1B 0.60 
ILMN_1250421 MMP12 0.60 
ILMN_1238886 CCL8 0.60 
ILMN_2954987 MB 0.60 
ILMN_2666018 MGLAP 0.60 
ILMN_2692644 BC054059 0.61 
ILMN_2443330 TTR 0.61 
ILMN_2778655 VCAM1 0.61 
ILMN_2595593 FXYD3 0.61 
ILMN_1222679 CIDEC 0.61 
ILMN_2661289 CSPRS 0.61 
ILMN_2774160 HSD11B1 0.61 
ILMN_2593774 1190002H23RIK 0.61 
ILMN_2675268 4933408F15 0.62 
ILMN_2731407 GDF3 0.62 
ILMN_2614655 GPNMB 0.62 
ILMN_2628629 CDH1 0.62 
ILMN_3136638 SNCA 0.62 
ILMN_2952275 ARG1 0.62 
ILMN_1225376 SMOC1 0.63 
ILMN_1253919 CCL3 0.63 
ILMN_3078388 CD209B 0.63 
ILMN_1259747 9230117N10RIK 0.63 
ILMN_2690603 SPP1 0.63 
ILMN_2614759 TIMP3 0.64 
ILMN_2944601 4933439C20RIK 0.64 
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ILMN_2609182 6530401D17RIK 0.64 
ILMN_2485323 TRF 0.64 
ILMN_2738825 ACTA1 0.64 
ILMN_3117876 CHI3L3 0.64 
ILMN_2625893 CES3 0.65 
ILMN_2727153 CLU 0.65 
ILMN_2507286 TNFSF13B 0.65 
ILMN_3049559 C4B 0.65 
ILMN_2725927 SERPINA3G 0.65 
ILMN_1241695 MS4A6D 0.65 
ILMN_2654700 DRP2 0.65 
ILMN_3115917 HSD11B1 0.65 
ILMN_2616565 SLC2A3 0.65 
ILMN_1226099 TNFSF13B 0.65 
ILMN_3103896 TIMP1 0.65 
ILMN_2741063 2810003C17RIK 0.66 
ILMN_1232716 CYP1B1 0.66 
ILMN_2593187 EGFL8 0.66 
 
 
Table S3: Differentially expressed sciatic nerve genes between young and 
aged after injury. Red: genes over-expressed in young greater than 1.5-Fold; 
Blue: genes over-expressed in aged greater than 1.5-Fold (less than 0.66). 
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